Preprint
Article

Research on Neonatal Conditions in Africa: Volume, Impact, Thematic Spectrum, and Collaboration from a Bibliometric Perspective

Altmetrics

Downloads

49

Views

26

Comments

0

This version is not peer-reviewed

Submitted:

01 October 2024

Posted:

02 October 2024

You are already at the latest version

Alerts
Abstract
The literature has addressed the negative impact of poor neonatal conditions (NC) across regions. This has drawn attention to the need to improve NC, particularly in Africa. NC research can make an important contribution. However, there is no study dedicated to this topic in Africa. Through a bibliometric analysis, we arrive at outputs that can inform scientists in planning ongoing or new NC research and those involved in developing and implementing strategies to combat poor NC. Using bibliometrics, the study identified the scientific knowledge on NC between 2000 and 2019, its visibility in the community, the main topics researched, and collaboration patterns.The results show that knowledge on NC has increased between 2000 and 2019, it is concentrated in a few African countries (Egypt, South Africa, Nigeria, Tanzania and Kenya), its visibility is below the world average, in general, maternal mortality is the most researched topic and collaborative activities are frequently, mainly international research collaboration (IRC), being the United States of America (USA) and the United Kingdom (UK) the main partners (they participated in 57% and 28% of all articles with IRC). The collaboration networks are fragile as 43%-67% of all links represent one article in 20 years.Ongoing or new research on NC in Africa should consider the main African players and their partners. There is a need to implement strategies to increase NC knowledge in other African countries, expand and strengthen the collaboration networks and diversify the sources of knowledge.
Keywords: 
Subject: Public Health and Healthcare  -   Public Health and Health Services

Introduction

In 2015, the United Nations General Assembly agreed on the 2030 Agenda for Sustainable Development. The agenda comprises 17 Sustainable Development Goals (SDGs) and 169 targets. The third SDG, Ensure healthy lives and promote well-being for all at all ages, is of great importance for Africa. The high burden of disease in Africa is responsible for high DALYs (a measure of the total burden of disease, expressed as the number of years lost due to illness, disability or early death) and consequently high GDP losses. A study looking at the productivity costs of disease in Africa estimates 629 603 271 DALYs in 2015, with NC responsible for 12% of those DALYs and an estimated productivity loss of Int$347 336 223 573 (International Dollars — a hypothetical unit of currency that has the same purchasing power parity that the USA dollar had in the USA at a given point in time) (WHO, 2019).
A study that examined the causes of under-five mortality showed that the mortality burden was highest in Africa in 2010 (3.6 million deaths) (Liu et al., 2012). The authors found that neonatal deaths account for 30% of total mortality and birth complications and intrapartum-related complications as the main causes. Recent studies continue to conclude that neonatal deaths account for a significant proportion of total deaths in Africa, particularly in sub-Saharan Africa (e.g. Ou et al., 2022; UN, 2022; Wang et al., 2014).
Considering these statistics, the international community recognized the need to develop and implement strategies to reduce the negative impact of limited NC. In this regard, NC research is crucial, although there is no study on the topic in Africa.
Bibliometrics allows for meaningful analysis of a particular topic, and this method can be used to identify strengths and weaknesses. The output from this analysis can assist: (1) scientists in ongoing or new NC research and (2) those responsible for policies to combat poor NC.
In this paper, I resorted to a bibliometric analysis to inform about the volume, impact, thematic spectrum, and collaboration patterns regarding NC research in Africa. Based on these results, I point out some implications for practice, policy and future research.
The paper is organized as follows: the next section provides a summary of the methodology (see Supporting Information (SI) for details), the Results and Discussion section presents the results of the bibliometric analysis and discusses its implications, and the Conclusions section presents the main findings.

Methods

Data Identification

I searched the keywords related to NC, validated by peers in Confraria & Wang, 2020, in titles, abstracts and keywords to find the relevant articles indexed in the Web of Science Core Collection (WoS) and published between 2000 and 2019 (see the search query in the Support Information (SI)). I extracted the metadata of 1784 articles published by at least one scientist (not all authors of a publication are scientists in the strict sense of the word, but for simplicity, I use this word to refer to the authors in the publications) whose affiliation is with an African institution (hereafter African scientists). The use of discipline–specific terms imposes limitations that affect the accuracy of the methodology due to the multiple meanings and variety of terms that can be used to represent a topic. I then analyzed each article and retrieved those referring to NC in Africa. The final set comprises 1250 articles. The limitations of the methodology are described in the SI.

Bibliometric Analysis

Volume

I used the number of articles to quantify the scientific knowledge on NC in Africa. Where possible, I resorted to longitudinal analyses to identify trends. I also identified the African countries researching NC.

Impact

I looked at the visibility of NC research by using, as a proxy, the number of citations. The number of citations depends on the citation culture of each field, type of document, and year of publication (Clarivate, 2021; Waltman, 2016). Then, I resorted to a normalized indicator: the Category Normalized Citation Impact (CNCI), available in InCites (Clarivate, 2021).
The CNCI of a document is the ratio between the number of citations received and that expected for documents of the same type, published in the same year and belonging to the same scientific field. If the CNCI for a particular document is above 1, the visibility of a document is above the world average, otherwise, it is below.
For document sets, I discussed their visibility using the median value. The CNCI is only addressed for sets with 20 or more articles (see the Methods in the SI for these decisions).

Thematic Spectrum

As for the thematic spectrum, I adopted the citation topics schema. This is a document-level classification available through the WoS (for more information on this schema, see the Methods in the SI). I used the micro-level to identify the topics covered in NC research. At this level, each paper is categorized into only one topic.
For each topic with 20 or more articles, I used the CNCI to determine its visibility.

Collaboration Activities

As for collaboration activities, I analyzed the patterns at the country and university level, domestic research collaboration (DRC) and IRC. The heuristics I followed can be found in the Methods in the SI.
After the identification of the countries, universities, and types of collaboration, I identified the:
  • number of collaborative articles, type of collaborations and partners. I supplemented the information with a longitudinal analysis where possible,
  • DRC by African country,
  • visibility by type of collaboration,
  • areas with more collaboration, and
  • collaboration networks and analyzed them using social network analysis.
In the networks, the nodes represent countries/universities and the links are the number of publications in which the scientists from the two countries/universities have participated. I used statistics as the density, degree, and eigencentrality (Cherven, 2015) to discuss the potential of these networks as enablers of knowledge flow.

Results and Discussion

Volume

The knowledge on NC has increased over time. In 2000, there are 15 articles indexed in WoS and in 2019, 196 (Figure 1). The growth can be described as exponential, with an annual growth rate of around 19%.
The production is concentrated in the period between 2010 and 2019, mainly in 2015–2019 when about 61% of the 1250 articles were published (Figure 1).
A large proportion of the scientific knowledge produced is the responsibility of a few African countries: Egypt, South Africa, Nigeria, Tanzania and Kenya were involved in 787 articles, representing about 63% of all articles (SI, Table 1). This suggests that knowledge may be concentrated in a few places, which is undesirable as the burden greatly affects the whole continent.
These countries are also consistently among the African leaders in the production of knowledge in general (e.g., Cerdeira, Mesquita, & Vieira, 2023; Mouton & Blanckenberg, 2018; Sooryamoorthy, 2021). Therefore, their national scientific systems are expected to have characteristics that put them in a satisfactory position regarding knowledge transfer to other African countries.
Over time, there have been no significant changes in the African countries with the highest contribution (SI, Table 1). Egypt has significantly increased its production; two papers were published in 2000–2004 and 150 in 2015–2019, the country with the highest number. The changes in 2015–2019 indicate that other countries might play a crucial role in NC research in the future. While Egypt, South Africa and Nigeria remain in the top 5, Tanzania and Kenya have been overtaken by Ethiopia. Uganda and Ghana have a similar number of articles to Tanzania.

Impact

The distribution of articles according to their impact is skewed (SI, Figure 1). There are a few articles with a high impact (60 articles have a CNCI of 5 or more) and many articles with a value below the world average (749 articles with a CNCI of less than one and 455 with 0.500 or less).
The impact of the articles is, generally, below the world average according to the median value (Figure 2, left plot). It is 0.754 the world average (SI, Table 2) considering all documents. It increased from 2000–2004 (articles published in this period) to 2010–214 and then declined (Figure 2, right plot), without reaching the world average. In 2015–2019, the median value is 0.85 of the world average. However, as mentioned before and shown in SI, Table 2, some articles have an outstanding impact (interquartile range (IQR) and P75).

Thematic Spectrum

The distribution by topic is skewed (SI, Table 3); 159 topics and those in the top 5 account for 45% of the 1250 articles. For 83 topics, the number of articles is one.
Maternal Mortality, Group B Streptococcus, Bilirubin, Preterm Labor, and Gestational Diabetes Mellitus dominate the top 5 across the period (Figure 3). This is partly a consequence of the unbalanced distribution of documents by period (these topics dominate the top 5 in 2015–2019, when the number of articles is highest). Over time, we see changes; Gastroschisis, Patent Ductus Arteriosus, Fetal Heart Rate, Malaria and Preeclampsia were in the top 5 in the first two periods.
For topics with 20 or more articles in 2000–2019, visibility is below the world average, except for Bilirubin, HIV Prevalence & Prophylaxis, Malaria, and Antibiotic Resistance, which are slightly above the world average (SI, Table 3 and Table 4). Articles on HIV Prevalence & Prophylaxis have the highest impact, median value of 1.105. The articles on Patent Ductus Arteriosus have the lowest visibility; 0.586 the world average.

Collaboration Activities

Overview of Research Collaboration

Collaborative activities are common in NC research (Figure 4) and have increased. In 2000–2019, there are 555 articles with DRC and 669 with IRC (SI, Table 5). The growth can be characterized as exponential, with an annual growth rate of about 23% for IRC and 17% for DRC. In 2000, collaborative activities are present in all articles and in 2019, in 98%. Considering 5-year periods, we see that DRC is more frequent than IRC in 2000–2004; it is about two times the frequency of IRC (Figure 4), although the number of articles is small. Over time, IRC has become more frequent and accounts for 54% of all articles in 2015–2019, while DRC accounts for 45% (SI, Table 5).
Among the types of IRC, collaboration between African scientists without the participation of non-African scientists (IRCintra) was rare. We find 19 articles in 2000–2019, and 16 in 2015–2019 (SI, Table 5).
Articles in which African scientists from various countries and non-African scientists (IRCinter_intra) contributed were practically non-existent until 2009. After that, the number of these articles began to increase; in 2015–2019 they represent 18.5 % of all articles (SI, Table 5).
This rare pattern of collaboration (IRCintra and IRCinter_intra) may not allow the development and establishment of networks among African scientists that permit them to address their local challenges. These collaborations provide insights to answer current research questions and offer African scientists the opportunity to share their previous experiences, acquired knowledge and the challenges in their countries through informal communication. As they interact and realize each other’s capabilities and interests, trusting relationships are formed. These relationships and previous collaborations can lead to new joint projects that address local issues (Cerdeira, Mesquita, & Vieira, 2023; Owusu-Nimo & Boshoff, 2017). In addition, trusting relationships may spread among the collaborators of African scientists involved in IRCintra and IRCintra_inter, increasing opportunities for collaboration with these scientists’ partners (Newman, 2001). In short, it is expected that all mechanisms involved in collaborative activities will contribute to building a stronger research network between African scientists from different countries with or without the presence of non-African scientists.
Collaboration between African scientists, all from the same country, and non-African scientists (IRCinter) is the most common, in 88.2% of all articles in 2000–2004 and 77.6% in 2015–2019 (SI, Table 5). The benefits of these joint activities can be maximized if the African scientists involved have well-established national and intra/interregional African networks. In this scenario, they can serve as a bridge between other African scientists representing their professional connections in Africa and the non-African scientists involved in IRCinter.

Collaboration Networks

If we look at the network behind NC research, we can speculate on the potential benefits of IRC from this perspective.
NC research is characterized by high geographical dispersion as the network consists of 129 countries (89 non-African and 40 African countries, SI, Figure 5). There are 5059 links, which account for 61% of all possible interactions given the number of countries involved. The interactions between non-African countries (the links connecting two non-African countries) dominate the network as they account for 57.4% of all links (SI, Figure 5), followed by the interactions between African and non-African countries, which account for 36.3% of all links. Finally, interactions between African countries account for 6.3% of all links. In the network, 2192 links (43.3% of all links) represent a single publication in 20 years.
Collaborations between African countries appear to be fragile, as the subnetwork related to these interactions has 60% of its links representing only one article in 20 years (Figure 5). When these links are removed, the number of African countries with links to another African country drops from 40 to 25.
The subnetwork of the collaborations between African and non-African countries (SI, Figure 6) also shows weaknesses, as the links representing one publication in 20 years account for 49% of all its links. The Republic of Congo, Liberia, South Sudan, and Togo, which also have a fragile position in Figure 5, albeit Togo to a lesser extent, lost all their connections to non-African countries when the links representing one publication are deleted (SI, Figure 7). In addition, African countries lost connections with 15 non-African countries (Albania, Armenia, Bhutan, Bosnia and Herzegovina, Haiti, Hungary, Jamaica, Kazakhstan, Latvia, Malta, Montenegro, Myanmar, North Macedonia, Syria and Yemen).
The subnetworks indicate that Ghana, Nigeria, Tanzania and Kenya can play an important role in the flow of knowledge, in the continent, and in establishing professional links between African countries. They are quite well connected with other African countries within and outside their region (28 countries in the case of Kenya and 29 for the others). South Africa can also be crucial but is not well connected within Southern Africa. In 20 years, it co-authored a single publication with Botswana. If we ignore the links representing one article, the top 5 consist of the same countries and Uganda also appears at the top.
These countries, in addition to Egypt and Zambia, have the highest number of connections to non-African countries. They are influential in the network, as they are connected to countries with many connections also as supported by the high values of eigencentrality (SI, Table 8).
Figure 5. Collaboration subnetwork between African countries in 2000–2019 (the subnetwork derived from Figure 5, SI).
Figure 5. Collaboration subnetwork between African countries in 2000–2019 (the subnetwork derived from Figure 5, SI).
Preprints 119956 g005
As for non-African countries, the USA and the UK are key players in the flow and access to knowledge as shown by the high number of connections and centrality (they have the highest values for degree and eigencentrality, SI, Table 8).
The role of these countries becomes even clearer when analyzing the number of jointly authored articles by African countries (SI, Table 7). They are among the 5 countries that collaborated the most with African countries in 2000–2019 and in each 5 years. In 2000–2019, about 57% and 28% of the articles with IRC have the collaboration of scientists from the USA and the UK, respectively.
Sweden, the Philippines, and Switzerland lost their positions in this top. Their contribution is limited to two and three articles respectively in 2000–2004 (SI, Table 7), while others such as India, Canada, Pakistan and France emerged, although Pakistan and France are no longer at the top in 2015–2019. The research with multinational clinical trials conducted in India, Pakistan, African countries and other regions could justify the high presence of India and Pakistan at the top.
627 universities participated in IRC (SI, Table 9), and they are present in 96% of all articles with IRC. The distribution of universities by region is asymmetrical, as non-African universities predominate, although those from Africa increased over time (SI, Table 10). In 2015–2019, there are 126 African universities, accounting for 22% of all universities. The distribution of universities by country is also skewed, as those from the USA represent 18.5% of all universities in 2000–2019, followed by the UK with 4.8%.
The University of London (UoL-GBR) is the leader given the number of articles in which it was involved in the entire period, followed by the University of California (UC-System-USA) (Table 1). Other well-known universities are present in the top 10, such as Harvard University (HU-USA), Johns Hopkins University (JHU-USA), the University of North Carolina (UNC-System-USA) and the University of Oxford (OX-GBR). As for African universities, the University of Malawi (UNIMA-MWI), the University of Makerere (Mak-UGA) and the University of Witwatersrand (Wits Univ-ZAF) published more articles with IRC in 2000–2019. Over time, the changes in the top 10 are not significant. We see changes from the first to the second 5-year period, but the number of articles we are dealing with is so small that an in-depth discussion is impossible.
Table 1. Universities in the top 10 (highlighted in blue) according to the number of publications with IRC in each period.
Table 1. Universities in the top 10 (highlighted in blue) according to the number of publications with IRC in each period.
Country Institution Pub (nº)
2000–2019 2000–2004 2005–2009 2010–2014 2015–2019
Egypt MA-EGY 10 0 4 1 5
Ethiopia AAU-ETH 15 1 0 2 12
Malawi UNIMA-MWI 42 1 4 9 28
Mozambique UEM-MOZ 6 1 0 2 3
Pakistan AKU-PAK 46 0 2 17 27
Tanzania MUHAS-TZA 31 2 6 11 12
South Africa Wits Univ-ZAF 39 0 4 11 24
Uganda Mak-UGA 44 1 3 10 30
Zimbabwe UZ-ZWE 10 2 0 2 6
Australia UNIMELB-AUS 17 2 3 4 8
Norway UiB-NOR 20 1 1 9 9
Sweden KI-SWE 17 2 2 6 7
UK OX-GBR 41 1 5 10 25
UK UoL-GBR 106 0 14 26 66
USA JHU-USA 53 4 9 17 23
USA CU-USA 33 2 2 3 26
USA HU-USA 57 2 6 15 34
USA UNC-System-USA 49 0 7 10 32
USA GWU-USA 17 0 4 6 7
USA UA-System-USA 35 0 2 17 16
USA UC-System-USA 65 0 3 16 46
USA UW-USA 35 0 3 11 21
The collaboration network has 627 universities and 48468 links (SI, Figure 8). The visible links represent 25% of the possible interactions between the participating universities. The interactions between non-African universities dominate the network as they account for 77% of all links (SI, Figure 8), followed by the interactions between African and non-African universities, which are 21% of all links. Finally, interactions between African universities account for 2% of the observed links.
The network is characterized by a dense core dominated by non-African universities. There are clusters of universities that are closely connected to this core. If we move from the core to the periphery, the network consists of small groups of universities with weak connections to each other and fragile connections to the core.
This network can be considered too fragile as 67% of the links represent a publication in 20 years. If these links are deleted, the network consists of 477 universities (397 and 80 African and non-African universities, respectively).
Regarding the subnetwork among African universities, it cannot be said that it is a mature and well-established network, as several universities have a very fragile position (SI, Figure 9). 17 out of 138 universities have no connections to other African universities; they are part of the network because they are only linked to non-African universities. 557 out of 804 links represent one publication in 20 years. If we delete these links, only 48 African universities will still be connected and most of the small groups of African universities, which are at the network periphery, disappear.
The University of Cairo in Egypt (CU-EGY), MUHAS-TZA in Tanzania, Wits Univ-ZAF in South Africa, University of Kinshasa in the Democratic Republic of Congo (UNIKIN-ZAR) and University of Cape Coast in Ghana (UCC-GHA), from different African regions, can play an important role in the flow of knowledge between African universities as they are linked to several universities in other countries from their region and also from other African regions, except Wits Univ-ZAF and UNIKIN-ZAR. Although they are linked to universities in other African regions, they have no joint publications with countries within their region.
It is important to know which African universities can play a crucial role in the flow of knowledge and the expansion of professional relationships within the continent and to identify those that stand out for their links with non-African universities. The role of the above universities is diminished by the absence or presence of a small number of links with non-African universities.
The subnetwork between African and non-African universities, which includes 600 universities (SI, Figure 10), is also fragile, as the number of links representing one publication is 6896 out of its 10409 links. Most African universities have at least one publication with non-African universities, as 127 out of 138 are in the subnetwork. However, the presence of African universities seems delicate as only 74 remain in the subnetwork if the links representing one publication are deleted. In addition, many connections with non-African universities are lost as the number of these universities drops to 239.
Despite these weaknesses, we find African universities that occupy an outstanding position. The universities highlighted above (SI, Figure 9), as well as the University of Ahmadu Bello (ABU-NGA), the University of Stellenbosch (SU-ZAF) and the University of Cape Town (UCT-ZAF) (from Nigeria and South Africa) have the most connections with non-African universities. They are also among the universities with the highest centrality in the network (except for UNIKIN-ZAR), as shown by the eigencentrality values (SI, Table 11).
Finally, as far as non-African universities is concerned, outstanding universities such as UoL-GBR, OX-GBR and UW-USA are important in NC research, as shown by their high number of connections and their centrality in the network (SI, Table 11). These institutions have the most connections to African universities (about 14% of their total connections).

DRC Activities

As for DRC, Egypt, Nigeria, South Africa and Tunisia are among the top 3 countries with the highest number of documents in each period, although, Tunisia’s presence is marginal as only two articles were identified in 2000–2004 (SI, Table 6). These countries account for 74% of all articles with DRC. Although the changes concerning DRC are positive for these countries, this concentration indicates a low level of interaction between African scientists within the boundaries of the remaining countries.
As for Egypt, Nigeria and South Africa, it seems that each country is trying to solve its local problems by drawing on local knowledge, as the number of articles with DRC increased, albeit at different rates.
South Africa, which had the highest number of articles with DRC in 2000–2004, about 47% of all articles in that period, was displaced in the following period by Nigeria, which has about 39% of all articles in 2005–2009. In 2010–2014, Nigeria lost its first place to Egypt, which retained the lead in 2015–2019. The relative weight of articles with DRC from South Africa decreased over time, while articles from Egypt increased, accounting for about 34% of all articles with DRC in 2015–2019.
The data indicates that Ethiopia has made a significant commitment to DRC over the last five years. While there were no interactions within the borders in the previous periods (SI, Table 6), articles with DRC in 2015–2019 account for 14% of all articles with DRC in that period.

Visibility and Thematic Spectrum of Collaborative Activities

Research involving scientists from several countries leads to results with greater visibility than research conducted only within borders, as the CNCI values show (SI, Table 12). The median value is 0.5 of the world average for articles with DRC, and the value has not changed much over time. As for the articles with IRC, the median values are very close to the world average, and the highest value is recorded for articles published in 2010–2014; 1.272 the world average (SI, Table 12). The highest visibility of articles with IRC was also highlighted in previous studies Vieira, 2023.
Although the articles with IRCinter are prevalent in NC research, articles with IRCinter_intra have a higher visibility (articles published in 2010–2014 and 2015–2019, SI, Table 13). Articles with IRCinter_intra and published in 2010–2014 have a median value that is twice as high as the world average and 1.5 times as high as for articles with IRCinter in the same period. For the most recent articles (2015–2019), visibility decreased for both types of IRC. -
Maternal Mortality, Group B Streptococcus, Bilirubin, Gestational Diabetes Mellitus and Preterm Labor collaborated the most in the entire period (SI, Table 14). Therefore, the distribution is very similar to Figure 3.
Maternal Mortality and Group B Streptococcus have the largest number of collaborative articles in each 5 years. However, the thematic spectrum is dynamic, with Bilirubin and Fetal Heart Rate emerging at the top in 2005–2009, Bilirubin maintaining its position and Preterm Labor appearing in the last period (SI, Table 14).
It has been argued that the scientific production of African countries is dependent on the contribution of foreign scientists Vieira & Cerdeira, 2022. However, the data show that different patterns can be found depending on the level of analysis.
Among the topics for which there are documents with IRC or DRC, IRC is the most common in 25 topics, and in the top 5, we have Maternal Mortality, Gestational Diabetes Mellitus, HIV Prevalence & Prophylaxis, and Malaria. The number of articles with IRC is about three times as high as those with DRC (SI, Table 15). As for Fetal Heart Rate, the distribution is more balanced, and the difference is one document.
DRC is the most frequent in 24 topics, and in the top 5 we find Group B Streptococcus, Bilirubin, Preeclampsia, Preterm Labor and Patent Ductus Arteriosus (SI, Table 15). Still, the differences between DRC and IRC are not as pronounced as in the previous case, except for Patent Ductus Arteriosus.
The IRC articles’ visibility is above that of articles with DRC for the topics with 20 or more articles (SI, Table 16). Except for Group B Streptococcus and Gestational Diabetes Mellitus, the visibility of articles with IRC is twice as high as that of articles with DRC. For these topics, the visibility regarding the presence of IRC is also close to or slightly above the world average, except for Bilirubin with a median value of 1.5 times the world average.

Conclusions

The literature shows that neonatal deaths account for a significant proportion of all deaths in children under 5 years of age in Africa. Poor NC is often cited as the main cause of neonatal deaths (Nieuwoudt, Mackay, & Mda, 2022; UN, 2024). Although there have been several efforts to improve NC in this region, no study addresses the scientific knowledge of NC. The quantity, impact, scientific spectrum and collaborations patterns behind this knowledge can be used by scientists in ongoing and new NC research and stakeholders developing and implementing strategies to combat poor NC.
I looked at the literature on NC in Africa and used a bibliometric analysis to describe NC research. The results are important for practice, policy, and future research.
NC research attracted the interest of the scientific community as the number of articles increased from 15 in 2000 to 196 in 2019. However, it is not examined if this research addresses local needs. Future research should focus on this.
NC research is concentrated in a few African countries: Egypt, South Africa, Nigeria, Tanzania and Kenya. Strategies are needed to increase research in other African countries, and they could consider involving these countries as partners.
NC research has low visibility, in general. However, some articles have aroused great interest. This is the case of Bilirubin research involving scientists from several countries. Future research should shed more light on this point. The low visibility could be because the results are not relevant in the context of high-income countries, as their scientific problems are different (Atal et al., 2018; Evans, Shim, & Ioannidis, 2014). In this situation, the main interested in the research’s findings are in Africa.
Maternal Mortality, Group B Streptococcus, Bilirubin, Preterm Labor, and Gestational Diabetes Mellitus are the most studied topics. Future research should investigate whether these topics represent the main challenges regarding NC. If this is not the case, the issues that need more attention should be prioritized.
NC research is highly collaborative, with IRC occurring most frequently, namely between African scientists from the same country and non-African scientists. Future research may look at the positive and negative consequences of this mainly from the perspective of the interactions between the academic, government and industrial sectors.
Research only between African scientists from different countries is rare. Strategies to expand and strengthen research collaboration should focus on these collaborations.
The networks behind NC research are fragile, as most links (43%-67%) between countries/universities represent one publication in 20 years. Ghana, Nigeria, South Africa, Tanzania, Kenya, Egypt and Zambia have high centrality in the network. CU-EGY, MUHAS-TZA, Wits Univ-ZAF, SU-ZAF, UCT-ZAF, UNIKIN-ZAR, UCC-GHA and ABU-NGA have the most linkages with African and non-African universities, except UNIKIN-ZAR, which has no linkages with African universities from other countries. Strategies addressing the flow of knowledge and expansion of networks within the continent should consider these countries/universities as possible bridges. Ongoing or new NC research should consider these countries/universities as possible partners.
The USA and the UK are the main partners, as are the universities of these countries, especially those known for their excellence (e.g. HU-USA, JHU-USA, UoL-GBR, OX-GBR). Strategies that address knowledge sources should emphasize geographical diversification, while maintaining links with the US and UK, to reduce dependence on knowledge from these countries.
Research with IRC has the highest visibility. Strategies aimed at attracting the scientific community should emphasize IRC but always ensure that research meets local needs.
Disclosure Statement: The authors report there are no competing interests to declare.
Support Information: The following supporting information can be downloaded at the website of this paper posted on Preprints.org. The support information includes additional information about the methods used and their main limitations. It also presents several tables, figures and networks that supplement the Results and Discussion section in the main text.

Methods

Data Identification

The search query used to get the publications from the WoS Core Collection is as follows:
((ts="Preterm birth" OR ts="Birth asphyxia" OR ts="birth trauma" OR ts="Neonatal sepsis" OR tss="neonatal infection*" OR ts="Gastroschisis" OR ts="Jaundice" OR ts="Necrotizing enterocolitis" OR ts="Persistent pulmonary hypertension of the newborn" OR ts="Intrauterine growth restriction" OR ts="Bronchopulmonary dysplasia" OR ts="infant apnoea" OR ts="infant respiratory distress syndrome" OR ts="asphyxia at birth" OR ts="anaemia in neonates" OR ts="neonatal alloimmune thrombocytopenia" OR ts="bronchopulmonary dysplasia" OR ts="cardiac failure in neonates" OR ts="hyaline membrane disease" OR ts="hypocalcaemia in neonates" OR ts="hypoglycaemia of the newborn" OR ts="hyponatraemia in neonates" OR ts="hypothermia in neonates" OR ts="intestinal obstruction in neonates" OR ts="pulmonar interstitial emphysema”) and (cu="South Africa" OR cu="Egypt" OR cu="Nigeria" OR cu="Ethiopia" OR cu=” Rep Congo” OR cu=”DEM Rep Congo” OR cu="Tanzania" OR cu="Kenya" OR cu="Algeria" OR cu="Sudan" OR cu=”south sudan” OR cu="MORocco" OR cu="Uganda" OR cu="Mozambique" OR cu="Ghana" OR cu="angola" OR cu="somalia" OR cu="Ivory Coast" OR cu=”cote ivoire” OR cu="Madagascar" OR cu="Cameroon" OR cu="Burkina Faso" OR cu="Niger" OR cu="Malawi" OR cu="zambia" OR cu="mali" OR cu="Senegal" OR cu="Zimbabwe" OR cu="Chad" OR cu="Tunisia" OR cu="Guinea" OR cu="Guinea bissau" OR cu=”Equat Guinea” OR cu="Rwanda" OR cu=" Benin" OR cu="Burundi" OR cu="Eritrea" OR cu="Sierra Leone" OR cu="Togo" OR cu="Libya" OR cu="CENT AFR REPUBL" OR cu="Mauritania" OR cu="Liberia" OR cu="Namibia" OR cu="Botswana" OR cu="Lesotho" OR cu="Gambia" OR cu="Gabon" OR cu="Mauritius" OR cu="Eswatini" OR cu=”swaziland” OR cu="Djibouti" OR cu="Comoros" OR cu="Cape Verde" OR cu=" SAO TOME & PRIN " OR cu="Seychelles") and py=2000–2019)

Limitations

As for the method used to extract the articles on NC, the less positive points must be emphasized.
Non-African scientists, mainly those from high-income countries (HICs) might conduct research on NC in Africa without the participation of African scientists, a phenomenon known in the literature as parachute science (e.g., Stefanoudis et al., 2021). However, we should emphasize the results from the literature of the research done by scientists from HICs on the greatest burden of disease. Most of the research on Medical and Health Sciences (M&HS), which includes NC, has been done by HICs and they have addressed their local scientific problems, which are very different from those of Africa (Atal et al., 2018; Evans, Shim, & Ioannidis, 2014). As for neonatal disorders, results have shown that disease-specific gaps exist in Sub-Saharan Africa (Atal et al., 2018) and that the burden is very prevalent in Africa in general (Ou et al., 2022).
In M&HS, in specific, research involving African and non-African scientists unveiled that while 67% of the total 520 clinical trials conducted in Africa addressed local scientific problems, in 14% of cases the research addressed the needs of developed countries. Therefore, I can not guarantee that all the NC research identified is related to the local needs in Africa.

Impact

Normally, when determined for a set of documents, the CNCI is the average value of the CNCI of all documents. However, when using this indicator, we must consider that the citation distribution of documents is typically skewed (Vieira & Gomes, 2010). We normally find a small number of documents highly cited and many documents with relatively few citations (Figure 1 in this document). The mean value is affected by highly cited documents therefore the average values might not represent well the impact/visibility. Thus, I decided to present the median, which is not affected by the presence of highly cited documents. The distribution of the values of CNCI (Figure 1, Figure 3, Figure 4 in this document) shows that indeed the average value is not a good choice.
When dealing with small sets of documents, the probability of finding a median value of zero is high given that many documents are never cited, and others given their recent publication did not have the time to be acknowledged by the scientific community. Therefore, I only discuss these indicators for sets with 20 or more articles. However, I present the values for sets with less than 20 documents only for information purposes.
Lastly, in calculating the CNCI, I used an open window, i.e. the count of citations represents the cumulative citations between the publication year and September 2023 (the moment when I collected the data from the WoS).

Thematic Spectrum

The citation topics schema names clusters of documents based on cited and citing relationships between documents (Potter, 2020). This is a three-level hierarchical document classification system. The macro, meso and micro level include 10, 326, and 2449 scientific fields, respectively. At the micro-level, each paper is categorized into only one topic. The schema is a dynamic one, meaning that every year the number of scientific fields can change. Some topics might require a change in the name, and others might be added. Therefore, every year, we have an update of the schema. The data presented here is based on the schema available for 2023.

Collaboration

As for collaboration, I followed the following heuristics:
  • Using the author’s affiliation(s) in the articles, I extracted information concerning the country and universities.
  • I only considered universities given that they are the main players in the discovery and creation of knowledge.
  • As for universities. I aggregated the information at the higher level of the organization (e.g., information is not available for departments or individual faculties belonging to a given university). In the case of the USA, the results are presented for the university system and not for the individual campuses. For example, the University of California is a university system composed of ten campuses. All the articles mentioning the different campuses of the university were considered as University of California.
  • As for IRC, I identified the articles that have at least two authors whose affiliations mention institutions located in two countries. Once the articles with IRC have been identified, I analyzed them with more detail and identified occurrences between: (1) African scientists all from the same country and non-African scientists (IRCinter); (2) only African scientists from different countries (IRCintra); (3) African scientists from different countries and non-African scientists (IRCinter-intra).
  • Concerning DRC, I considered articles that only represent collaborations between scientists working in the same or different institutions in each African country.

Results

Volume

Table 1. Number of articles on NC by African country, for the whole period and by 5-year periods.
Table 1. Number of articles on NC by African country, for the whole period and by 5-year periods.
Country Pub (nº)
2000–2019 2000–2004 2005–2009 2010–2014 2015–2019
EGYPT 232 2 21 59 150
SOUTH AFRICA 212 21 27 51 113
NIGERIA 186 9 27 52 98
TANZANIA 101 4 13 29 55
KENYA 92 4 4 24 60
ETHIOPIA 81 2 0 5 74
UGANDA 77 1 4 18 54
GHANA 75 1 6 15 53
MALAWI 64 2 6 10 46
ZAMBIA 52 0 3 18 31
GAMBIA 31 2 3 4 22
TUNISIA 24 2 5 6 11
CONGO DEMOCRATIC REPUBLIC 21 0 2 5 14
MOROCCO 20 0 1 8 11
CAMEROON 20 0 0 7 13
ZIMBABWE 20 2 1 4 13
SUDAN 19 1 4 3 11
SENEGAL 19 1 3 6 9
BENIN 14 0 1 4 9
BURKINA FASO 13 0 0 1 12
MOZAMBIQUE 13 1 0 3 9
RWANDA 13 0 0 1 12
COTE IVOIRE 10 0 0 3 7
MADAGASCAR 10 0 0 2 8
BOTSWANA 10 0 0 0 10
GABON 8 0 0 2 6
MALI 6 0 0 5 1
NIGER 5 0 0 0 5
ALGERIA 4 1 0 1 2
TOGO 3 0 1 0 2
SIERRA LEONE 3 0 0 0 3
BURUNDI 3 0 0 0 3
CONGO PEOPLES REP 3 0 0 1 1
CENT AFR REPUBL 2 0 0 0 2
GUINEA BISSAU 2 0 0 1 1
SOUTH SUDAN 2 0 0 0 2
LIBYA 2 0 0 1 1
ANGOLA 2 1 0 0 1
CHAD 2 0 0 0 2
LIBERIA 1 0 0 0 1
ERITREA 1 0 1 0 0

Impact

Figure 1. Distribution of the CNCI of the articles on NC published between 2000 and 2019. Due to visualization purposes, only articles with a CNCI equal to or below 20 were considered (they represent 99.2% of the total articles).
Figure 1. Distribution of the CNCI of the articles on NC published between 2000 and 2019. Due to visualization purposes, only articles with a CNCI equal to or below 20 were considered (they represent 99.2% of the total articles).
Preprints 119956 g006
Figure 2. Evolution of the average CNCI for the articles on NC.
Figure 2. Evolution of the average CNCI for the articles on NC.
Preprints 119956 g007
Figure 3. Boxplot for the values of CNCI of the articles published between 2000 and 2019.
Figure 3. Boxplot for the values of CNCI of the articles published between 2000 and 2019.
Preprints 119956 g008
Figure 4. Boxplot for the values of CNCI of the articles by period.
Figure 4. Boxplot for the values of CNCI of the articles by period.
Preprints 119956 g009
Table 2. Descriptive statistics for the CNCI.
Table 2. Descriptive statistics for the CNCI.
Statistics CNCI
2000–2019 2000–2004 2005–2009 2010–2014 2015–2019
Median 0.754 0.430 0.721 0.850 0.744
Stand. Dev. 9.136 0.576 1.221 13.877 7.562
P25 0.308 0.236 0.328 0.409 0.294
P75 1.535 0.857 1.361 1.748 1.536
IQR 1.227 0.622 1.033 1.339 1.242
Observations 1250

Thematic Spectrum

Table 3. Number of articles on NC by topic.
Table 3. Number of articles on NC by topic.
Micro-topic Pub(nº)
2000–2004 2005–2009 2010–2014 2015–2019 2000–2019
1.156.381 Maternal Mortality 8 21 57 108 194
1.23.1757 Group B Streptococcus 8 9 28 83 128
1.117.1389 Bilirubin 1 8 24 58 91
1.72.182 Gestational Diabetes Mellitus 3 7 26 54 90
1.72.924 Preterm Labor 2 6 11 45 64
1.72.531 Preeclampsia 3 9 11 37 60
1.66.11 HIV Prevalence & Prophylaxis 1 5 12 31 49
1.217.59 Malaria 1 6 15 18 40
1.72.922 Fetal Heart Rate 0 9 6 23 38
1.72.1732 Patent Ductus Arteriosus 3 1 9 12 25
1.72.748 Preterm Infants 0 1 9 13 23
1.23.146 Antibiotic Resistance 0 1 3 17 21
1.216.2287 Gastroschisis 3 2 1 14 20
1.44.1198 Food Insecurity 0 0 9 10 19
1.72.808 Breech Presentation 1 1 1 14 17
1.184.573 Iron Overload 1 1 4 7 13
1.248.655 Chlamydia Trachomatis 0 2 1 10 13
1.72.891 Breastfeeding 1 2 2 7 12
1.125.1718 Hepatitis E Virus 2 3 1 5 11
1.72.1072 Postpartum Depression 0 1 1 9 11
1.80.279 Vitamin D 0 1 0 10 11
1.225.2074 Methemoglobinemia 0 0 6 4 10
1.49.468 Oral Health 0 0 2 8 10
1.154.1057 Pulmonary Surfactant 1 2 2 4 9
1.150.1148 Deaf 0 3 2 3 8
1.156.2047 Global Surgery 0 1 2 5 8
1.157.728 Biliary Atresia 1 1 1 5 8
1.75.326 Antiphospholipid Syndrome 0 1 4 3 8
1.81.979 Twin-Twin Transfusion Syndrome 0 1 4 3 8
8.124.552 Air Pollution 0 0 1 6 7
1.120.384 Gut Microbiota 0 0 2 4 6
1.55.830 Acute Kidney Injury 0 2 0 4 6
1.148.94 Candida Albicans 0 0 2 3 5
1.151.222 Laparoscopic Cholecystectomy 0 0 0 5 5
1.225.626 Sickle Cell Disease 0 0 1 4 5
1.103.1225 ITP 0 1 3 0 4
1.104.975 Respiratory Syncytial Virus 1 0 1 2 4
1.137.217 Melatonin 0 0 0 4 4
1.154.360 Procalcitonin 0 0 1 3 4
1.161.711 Cytomegalovirus 0 2 1 1 4
1.23.173 Staphylococcus Aureus 0 0 0 4 4
1.42.678 Listeria Monocytogenes 1 1 0 2 4
1.82.1066 Cerebral Palsy 0 0 3 1 4
1.104.126 Influenza 0 0 1 2 3
1.125.275 HBV 0 0 0 3 3
1.128.482 Contraception 0 0 0 3 3
1.194.273 Mycobacterium Tuberculosis & Leprosy 0 0 1 2 3
1.216.1563 Volvulus 0 0 0 3 3
1.216.1996 Pneumomediastinum 0 0 1 2 3
1.222.143 Epilepsy 1 1 1 0 3
1.231.432 Homocysteine 1 0 1 1 3
1.248.1317 Mycoplasma 0 0 2 1 3
1.248.2104 Trichomonas Vaginalis 1 0 1 1 3
1.257.983 Hydrocephalus 0 0 2 1 3
1.37.309 Congenital Heart Disease 0 0 1 2 3
1.72.1745 Hyperemesis Gravidarum 0 0 2 1 3
1.95.723 Irritable Bowel Syndrome 0 2 1 0 3
3.91.920 Selenium 0 1 0 2 3
6.24.858 Intimate Partner Violence 0 0 1 2 3
1.125.83 HCV 1 1 0 0 2
1.141.407 Acute Promyelocytic Leukemia 1 0 0 1 2
1.142.832 Fecal Incontinence 0 0 1 1 2
1.161.315 HSV-1 0 0 2 0 2
1.228.200 Dengue 0 0 1 1 2
1.228.994 Ebola Virus 0 0 0 2 2
1.23.1036 Surgical Site Infection 1 0 0 1 2
1.23.422 Gentamicin 0 0 1 1 2
1.235.1679 Foreign Body 0 0 0 2 2
1.258.1958 Leptospirosis 0 0 0 2 2
1.286.845 Complement 0 1 0 1 2
1.42.545 STEC 0 0 0 2 2
1.6.351 Endotoxin 0 0 1 1 2
1.81.1272 HLA-G 0 0 0 2 2
1.81.1408 Fertility Preservation 0 0 1 1 2
4.61.1124 Rough Sets 0 0 1 1 2
6.178.516 Divorce 0 0 0 2 2
1.100.1284 Fetal Alcohol Syndrome 0 0 0 1 1
1.104.1770 Pertussis 0 0 0 1 1
1.104.901 Foot-And-Mouth Disease Virus 0 0 0 1 1
1.105.1677 Vertebral Artery Dissection 0 0 1 0 1
1.111.162 Hepatocellular Carcinoma 1 0 0 0 1
1.117.1309 Acetaminophen 0 0 1 0 1
1.127.1303 Endothelin 0 0 1 0 1
1.128.1489 Hysteroscopy 0 0 0 1 1
1.128.1521 Ectopic Pregnancy 0 0 0 1 1
1.132.2267 Clubfoot 0 0 0 1 1
1.132.759 Matrix Metalloproteinases 0 1 0 0 1
1.136.1749 Down Syndrome 0 0 0 1 1
1.136.1780 Family Quality Of Life 0 0 0 1 1
1.136.283 Autism 0 0 0 1 1
1.14.1293 Emergency Department 0 0 0 1 1
1.14.1359 Interprofessional Education 0 0 0 1 1
1.142.1628 Urinary Diversion 1 0 0 0 1
1.154.1088 Intensive Care 0 0 0 1 1
1.154.277 Mechanical Ventilation 0 0 0 1 1
1.155.598 Informed Consent 0 0 0 1 1
1.158.2138 Porokeratosis 0 0 0 1 1
1.163.446 Schistosomiasis 0 0 0 1 1
1.164.1871 Menarche 0 0 0 1 1
1.168.671 Vascular Access 0 0 1 0 1
1.179.108 Human Papillomavirus 0 0 0 1 1
1.184.1030 Erythropoietin 1 0 0 0 1
1.184.653 Zinc 0 0 0 1 1
1.186.1008 Nuchal Translucency 0 0 0 1 1
1.186.948 Digeorge Syndrome 0 0 0 1 1
1.195.1341 Enteric Nervous System 1 0 0 0 1
1.199.1048 Pleurodesis 1 0 0 0 1
1.213.168 Hypothyroidism 0 0 1 0 1
1.216.2098 Intussusception 0 1 0 0 1
1.217.1038 Toxoplasma Gondii 0 0 1 0 1
1.225.1476 Alloimmunization 0 0 0 1 1
1.225.786 Spectrin 0 0 0 1 1
1.23.1397 Urinary Tract Infection 0 0 0 1 1
1.23.714 Neisseria Meningitidis 0 0 0 1 1
1.231.1650 Thiamine 0 0 1 0 1
1.235.1617 Deglutition 0 0 0 1 1
1.236.1155 Capsule Endoscopy 0 0 1 0 1
1.236.312 Portal Hypertension 0 0 0 1 1
1.243.1012 Vesicoureteral Reflux 0 0 1 0 1
1.246.710 Rotavirus 1 0 0 0 1
1.248.1683 Syphilis 0 0 1 0 1
1.258.227 Lyme Disease 0 0 1 0 1
1.26.107 Adiponectin 0 0 0 1 1
1.26.337 Leptin 0 1 0 0 1
1.261.596 Trypanosoma Cruzi 0 1 0 0 1
1.266.1068 Pressure Ulcer 0 0 0 1 1
1.278.1796 Neuroblastoma 0 0 1 0 1
1.281.1236 Amyloidosis 0 0 1 0 1
1.324.2020 Tetanus 0 1 0 0 1
1.34.1657 Elbow 0 0 1 0 1
1.36.2059 Retinopathy Of Prematurity 0 0 0 1 1
1.37.467 Echocardiography 0 0 1 0 1
1.49.1061 Endodontics 0 0 0 1 1
1.5.1674 Ketogenic Diet 0 1 0 0 1
1.5.420 Cortisol 0 0 0 1 1
1.54.1401 Genome Editing 0 0 1 0 1
1.54.958 HMGB1 0 1 0 0 1
1.55.1904 ACE Gene 0 0 0 1 1
1.6.1437 Common Variable Immunodeficiency 0 0 1 0 1
1.6.452 Somatic Hypermutation 0 0 0 1 1
1.6.609 Toll-like Receptors 0 0 0 1 1
1.65.192 COPD 0 0 1 0 1
1.66.1615 Aids Dementia Complex 0 0 0 1 1
1.68.256 Docosahexaenoic Acid 0 0 0 1 1
1.68.707 Alpha-Tocopherol 0 1 0 0 1
1.71.2048 Mean Platelet Volume 0 0 0 1 1
1.72.1710 Postpartum Hemorrhage 0 0 0 1 1
1.82.1298 Spinal Cord Injury Rehabilitation 0 0 0 1 1
1.94.1664 VKORC1 1 0 0 0 1
1.95.387 Helicobacter Pylori 0 0 0 1 1
1.95.801 Cimetidine 0 0 1 0 1
3.16.1496 Ethnobotany 0 0 0 1 1
3.171.1011 Carotenoids 0 0 0 1 1
3.180.2418 Alginate Lyase 0 0 0 1 1
3.198.400 Mycotoxins 0 0 1 0 1
3.91.496 Cadmium 0 0 0 1 1
6.146.734 Anthropology 0 0 0 1 1
6.73.2331 Health Locus of Control 0 0 0 1 1
8.124.1648 Heat Waves 0 0 0 1 1
Table 4. Values of the CNCI by topic. Note: for several topics, the number of articles is below 20.
Table 4. Values of the CNCI by topic. Note: for several topics, the number of articles is below 20.
Micro-topic CNCI (median)
2000–2004 2005–2009 2010–2014 2015–2019 2000–2019
1.156.381 Maternal Mortality 0.692 1.247 1.128 0.810 0.865
1.23.1757 Group B Streptococcus 0.907 0.449 0.989 0.851 0.851
1.117.1389 Bilirubin 1.034 1.129 1.127 0.900 1.034
1.72.182 Gestational Diabetes Mellitus 0.509 0.571 0.856 1.219 0.885
1.72.924 Preterm Labor 0.296 1.070 1.183 0.706 0.728
1.72.531 Preeclampsia 0.561 0.832 0.528 0.732 0.650
1.66.11 HIV Prevalence & Prophylaxis 1.747 0.387 0.713 1.182 1.105
1.217.59 Malaria 0.155 0.732 1.123 0.879 1.012
1.72.922 Fetal Heart Rate 0.514 2.879 0.883 0.775
1.72.1732 Patent Ductus Arteriosus 0.378 0.836 0.607 0.538 0.586
1.72.748 Preterm Infants 0.355 0.203 0.808 0.724
1.23.146 Antibiotic Resistance 0.700 0.981 1.087 1.013
1.216.2287 Gastroschisis 0.716 1.595 0.488 0.551 0.605
1.44.1198 Food Insecurity 1.291 1.044 1.246
1.72.808 Breech Presentation 0.115 0.428 32.230 0.623 0.508
1.184.573 Iron Overload 0.673 2.516 1.072 1.267 1.267
1.248.655 Chlamydia Trachomatis 1.413 0.504 1.092 1.041
1.72.891 Breastfeeding 0.855 0.682 0.615 1.024 0.705
1.125.1718 Hepatitis E Virus 0.731 3.131 0.561 0.981 0.981
1.72.1072 Postpartum Depression 0.328 0.953 1.571 1.440
1.80.279 Vitamin D 2.210 0.611 0.611
1.225.2074 Methemoglobinemia 0.923 0.893 0.893
1.49.468 Oral Health 1.213 1.003 1.200
1.154.1057 Pulmonary Surfactant 0.125 0.340 1.314 0.347 0.405
1.150.1148 Deaf 0.854 0.262 0.690 0.769
1.156.2047 Global Surgery 0.383 1.792 1.760 1.084
1.157.728 Biliary Atresia 0.855 0.224 0.425 0.264 0.279
1.75.326 Antiphospholipid Syndrome 1.917 0.560 0.297 0.600
1.81.979 Twin-Twin Transfusion Syndrome 0.299 0.739 0.000 0.279
8.124.552 Air Pollution 0.631 0.126 0.144
1.120.384 Gut Microbiota 0.297 0.779 0.292
1.55.830 Acute Kidney Injury 0.555 0.059 0.213
1.148.94 Candida Albicans 0.408 1.067 0.782
1.151.222 Laparoscopic Cholecystectomy 0.058 0.058
1.225.626 Sickle Cell Disease 1.752 0.330 0.366
1.103.1225 ITP 0.184 0.270 0.227
1.104.975 Respiratory Syncytial Virus 0.000 2.082 0.951 0.951
1.137.217 Melatonin 0.526 0.526
1.154.360 Procalcitonin 1.875 0.656 1.265
1.161.711 Cytomegalovirus 0.067 2.382 0.057 0.095
1.23.173 Staphylococcus Aureus 0.487 0.487
1.42.678 Listeria Monocytogenes 0.020 1.330 0.247 0.247
1.82.1066 Cerebral Palsy 0.667 0.741 0.704
1.104.126 Influenza 0.225 4.503 0.323
1.125.275 HBV 0.086 0.086
1.128.482 Contraception 0.273 0.273
1.194.273 Mycobacterium Tuberculosis & Leprosy 14.577 0.506 0.757
1.216.1563 Volvulus 1.147 1.147
1.216.1996 Pneumomediastinum 0.000 0.940 0.266
1.222.143 Epilepsy 0.411 2.051 0.505 0.505
1.231.432 Homocysteine 0.625 0.782 1.378 0.782
1.248.1317 Mycoplasma 1.097 0.413 0.524
1.248.2104 Trichomonas Vaginalis 2.165 0.828 0.983 0.983
1.257.983 Hydrocephalus 2.215 0.473 1.570
1.37.309 Congenital Heart Disease 1.896 1.470 1.896
1.72.1745 Hyperemesis Gravidarum 0.473 0.376 0.376
1.95.723 Irritable Bowel Syndrome 0.389 1.004 0.721
3.91.920 Selenium 0.590 0.190 0.260
6.24.858 Intimate Partner Violence 2.078 5.989 4.888
1.125.83 HCV 0.546 1.320 0.933
1.141.407 Acute Promyelocytic Leukemia 0.278 2.227 1.253
1.142.832 Fecal Incontinence 0.231 2.110 1.171
1.161.315 HSV-1 0.625 0.625
1.228.200 Dengue 0.273 1.134 0.703
1.228.994 Ebola Virus 0.330 0.330
1.23.1036 Surgical Site Infection 0.387 0.324 0.355
1.23.422 Gentamicin 0.628 0.401 0.514
1.235.1679 Foreign Body 0.471 0.471
1.258.1958 Leptospirosis 0.373 0.373
1.286.845 Complement 0.193 0.384 0.288
1.42.545 STEC 0.605 0.605
1.6.351 Endotoxin 0.890 0.936 0.913
1.81.1272 HLA-G 0.554 0.554
1.81.1408 Fertility Preservation 1.008 0.111 0.559
4.61.1124 Rough Sets 0.966 0.589 0.777
6.178.516 Divorce 2.074 2.074
1.100.1284 Fetal Alcohol Syndrome 1.536 1.536
1.104.1770 Pertussis 0.924 0.924
1.104.901 Foot-And-Mouth Disease Virus 1.438 1.438
1.105.1677 Vertebral Artery Dissection 0.978 0.978
1.111.162 Hepatocellular Carcinoma 0.197 0.197
1.117.1309 Acetaminophen 0.178 0.178
1.127.1303 Endothelin 0.810 0.810
1.128.1489 Hysteroscopy 0.287 0.287
1.128.1521 Ectopic Pregnancy 3.365 3.365
1.132.2267 Clubfoot 1.649 1.649
1.132.759 Matrix Metalloproteinases 1.198 1.198
1.136.1749 Down Syndrome 0.225 0.225
1.136.1780 Family Quality Of Life 0.931 0.931
1.136.283 Autism 0.301 0.301
1.14.1293 Emergency Department 0.192 0.192
1.14.1359 Interprofessional Education 0.637 0.637
1.142.1628 Urinary Diversion 0.965 0.965
1.154.1088 Intensive Care 0.144 0.144
1.154.277 Mechanical Ventilation 0.037 0.037
1.155.598 Informed Consent 0.495 0.495
1.158.2138 Porokeratosis 1.291 1.291
1.163.446 Schistosomiasis 2.650 2.650
1.164.1871 Menarche 0.271 0.271
1.168.671 Vascular Access 0.337 0.337
1.179.108 Human Papillomavirus 0.776 0.776
1.184.1030 Erythropoietin 0.056 0.056
1.184.653 Zinc 1.264 1.264
1.186.1008 Nuchal Translucency 1.270 1.270
1.186.948 Digeorge Syndrome 0.070 0.070
1.195.1341 Enteric Nervous System 0.590 0.590
1.199.1048 Pleurodesis 0.857 0.857
1.213.168 Hypothyroidism 0.000 0.000
1.216.2098 Intussusception 0.134 0.134
1.217.1038 Toxoplasma Gondii 0.755 0.755
1.225.1476 Alloimmunization 0.492 0.492
1.225.786 Spectrin 0.000 0.000
1.23.1397 Urinary Tract Infection 0.704 0.704
1.23.714 Neisseria Meningitidis 0.000 0.000
1.231.1650 Thiamine 0.447 0.447
1.235.1617 Deglutition 0.324 0.324
1.236.1155 Capsule Endoscopy 0.325 0.325
1.236.312 Portal Hypertension 0.000 0.000
1.243.1012 Vesicoureteral Reflux 0.621 0.621
1.246.710 Rotavirus 0.620 0.620
1.248.1683 Syphilis 0.597 0.597
1.258.227 Lyme Disease 3.590 3.590
1.26.107 Adiponectin 0.631 0.631
1.26.337 Leptin 0.794 0.794
1.261.596 Trypanosoma Cruzi 0.286 0.286
1.266.1068 Pressure Ulcer 1.124 1.124
1.278.1796 Neuroblastoma 0.057 0.057
1.281.1236 Amyloidosis 0.816 0.816
1.324.2020 Tetanus 0.766 0.766
1.34.1657 Elbow 0.071 0.071
1.36.2059 Retinopathy Of Prematurity 0.599 0.599
1.37.467 Echocardiography 0.380 0.380
1.49.1061 Endodontics 1.046 1.046
1.5.1674 Ketogenic Diet 0.000 0.000
1.5.420 Cortisol 1.267 1.267
1.54.1401 Genome Editing 0.923 0.923
1.54.958 HMGB1 0.784 0.784
1.55.1904 ACE Gene 0.229 0.229
1.6.1437 Common Variable Immunodeficiency 0.349 0.349
1.6.452 Somatic Hypermutation 0.000 0.000
1.6.609 Toll-like Receptors 0.165 0.165
1.65.192 COPD 187.114 187.114
1.66.1615 Aids Dementia Complex 4.164 4.164
1.68.256 Docosahexaenoic Acid 0.625 0.625
1.68.707 Alpha-Tocopherol 1.361 1.361
1.71.2048 Mean Platelet Volume 0.405 0.405
1.72.1710 Postpartum Hemorrhage 0.000 0.000
1.82.1298 Spinal Cord Injury Rehabilitation 3.041 3.041
1.94.1664 VKORC1 0.081 0.081
1.95.387 Helicobacter Pylori 0.466 0.466
1.95.801 Cimetidine 0.233 0.233
3.16.1496 Ethnobotany 0.658 0.658
3.171.1011 Carotenoids 0.531 0.531
3.180.2418 Alginate Lyase 0.425 0.425
3.198.400 Mycotoxins 3.158 3.158
3.91.496 Cadmium 0.000 0.000
6.146.734 Anthropology 2.034 2.034
6.73.2331 Health Locus of Control 2.211 2.211
8.124.1648 Heat Waves 0.666 0.666

Collaboration

Table 5. The number and percentage of articles by type of collaboration and period of publication.
Table 5. The number and percentage of articles by type of collaboration and period of publication.
Period Collaboration
DRC (nº) IRC (nº) no_coll (nº) DRC (%) IRC (%) no_coll(%)
2000–2019 555 669 26 44.4 53.5 2.1
2000–2004 32 17 6 58.2 30.9 10.9
2005–2009 57 67 1 45.6 53.6 0.8
2010–2014 122 179 11 39.1 57.4 3.5
2015–2019 344 406 8 45.4 53.6 1.1
Period IRCintra(nº) IRCinter(nº) IRCinter_intra (nº) IRCintra(%) IRCinter(%) IRCinter_intra (%)
2000–2019 19 541 109 2.8 80.9 16.3
2000–2004 0 15 2 0.0 88.2 11.8
2005–2009 1 60 6 1.5 89.6 9.0
2010–2014 2 151 26 1.1 84.4 14.5
2015–2019 16 315 75 3.9 77.6 18.5
Table 6. Number of articles with DRC by African country.
Table 6. Number of articles with DRC by African country.
Country Pub (nº)
2000–2019 2000–2004 2005–2009 2010–2014 2015–2019
EGYPT 167 2 9 38 118
NIGERIA 116 7 22 32 55
SOUTH AFRICA 107 15 15 19 58
ETHIOPIA 51 0 0 2 49
TUNISIA 18 2 4 4 8
MOROCCO 14 0 0 8 6
CAMEROON 11 0 0 5 6
TANZANIA 11 1 1 3 6
GHANA 11 1 2 0 8
SUDAN 9 1 1 3 4
SENEGAL 7 1 0 2 4
UGANDA 6 0 0 1 5
KENYA 6 1 0 1 4
BENIN 3 0 0 1 2
TOGO 2 0 1 0 1
MALI 2 0 0 2 0
BURKINA FASO 2 0 0 0 2
ZIMBABWE 2 0 0 1 1
MADAGASCAR 2 0 0 0 2
CONGO DEMOCRATIC REPUBLIC 2 0 0 0 2
MALAWI 2 0 1 0 1
ERITREA 1 0 1 0 0
NIGER 1 0 0 0 1
ALGERIA 1 1 0 0 0
GABON 1 0 0 0 1
Table 7. The number of articles with the collaboration of scientists from non-African countries.
Table 7. The number of articles with the collaboration of scientists from non-African countries.
Country Pub (nº)
2000–2019 2000–2004 2005–2009 2010–2014 2015–2019
USA 384 8 34 110 232
UK 188 3 22 46 117
India 63 0 5 17 41
Australia 55 2 5 10 38
Switzerland 52 3 4 13 32
Canada 51 0 1 8 42
Pakistan 51 0 2 17 32
France 47 0 7 15 25
The Netherlands 43 0 4 9 30
Norway 42 1 2 13 26
Finland 33 1 0 5 27
Germany 33 1 2 7 23
Brazil 32 0 0 14 18
Sweden 32 2 3 11 16
Belgium 32 1 0 9 22
Spain 24 0 0 5 19
Bangladesh 22 0 3 3 16
Denmark 22 0 0 6 16
China 21 0 0 8 13
Argentina 21 0 1 4 16
Italy 20 0 0 6 14
Saudi Arabia 15 0 0 4 11
Guatemala 15 0 0 3 12
Thailand 13 0 0 4 9
Singapore 10 0 0 2 8
Japan 10 0 1 5 4
Nepal 9 0 0 1 8
Indonesia 8 0 1 0 7
Vietnam 8 0 1 1 6
Austria 8 0 0 2 6
Chile 7 0 0 3 4
Philippines 7 2 0 0 5
Mexico 7 0 0 1 6
New Zealand 7 0 0 1 6
Oman 7 0 0 4 3
Turkey 7 0 0 1 6
Malaysia 6 0 0 1 5
Israel 6 0 1 2 3
Peru 5 0 1 0 4
Ireland 5 0 0 1 4
United Arab Emirates 5 0 0 1 4
Jordan 4 0 0 0 4
Russia 4 0 0 1 3
Colombia 4 0 0 0 4
Lebanon 4 0 1 0 3
South Korea 4 0 0 0 4
Portugal 4 0 0 0 4
Czechia 4 0 2 1 1
Bolivia 4 0 1 1 2
Costa Rica 3 0 0 0 3
Bahrain 3 0 0 0 3
Greece 3 0 0 0 3
Poland 3 0 0 0 3
Iran 3 0 0 0 3
Serbia 3 0 0 0 3
Papua New Guinea 3 1 0 0 2
Romania 3 0 0 0 3
Luxembourg 3 0 0 0 3
Slovakia 3 0 0 0 3
Uruguay 3 0 0 1 2
Qatar 3 0 0 0 3
Sri Lanka 3 0 0 1 2
Kyrgyzstan 3 0 0 0 3
Croatia 3 0 1 1 1
Lithuania 3 0 0 0 3
Cambodia 3 0 0 1 2
Micronesia 2 0 0 0 2
Iceland 2 0 0 0 2
Iraq 2 0 0 0 2
Estonia 2 0 0 0 2
Ukraine 2 0 0 0 2
Georgia 2 0 0 0 2
Panama 2 0 0 1 1
Slovenia 2 0 0 0 2
Myanmar 1 0 0 0 1
Bhutan 1 0 0 0 1
Yemen 1 0 0 0 1
Kazakhstan 1 0 0 0 1
Jamaica 1 0 0 1 0
Albania 1 0 0 0 1
Malta 1 0 0 0 1
Latvia 1 0 0 0 1
Armenia 1 0 0 0 1
Bosnia and Herzegovina 1 0 0 0 1
North Macedonia 1 0 0 0 1
Montenegro 1 0 0 0 1
Hungary 1 0 0 0 1
Syria 1 0 0 0 1
Haiti 1 0 0 0 1
Table 8. Statistics for the countries in the collaboration network representing the whole period.
Table 8. Statistics for the countries in the collaboration network representing the whole period.
Country Degree Eigencentrality
Algeria 92 0.901
Angola 84 0.836
Benin 93 0.904
Botswana 5 0.038
Burkina Faso 36 0.338
Burundi 76 0.746
Cameroon 92 0.901
Central African Republic 6 0.059
Chad 11 0.106
Congo 5 0.051
Cote Ivoire 87 0.844
Democratic Republic of the Congo 82 0.776
Egypt 101 0.935
Ethiopia 93 0.906
Gabon 29 0.276
Gambia 89 0.852
Ghana 112 0.986
Guinea-Bissau 28 0.267
Kenya 101 0.932
Liberia 1 0.011
Libya 29 0.270
Madagascar 5 0.034
Malawi 47 0.423
Mali 8 0.077
Morocco 85 0.844
Mozambique 82 0.799
Niger 2 0.021
Nigeria 113 0.987
Rwanda 99 0.923
Senegal 25 0.219
Sierra Leone 27 0.250
South Africa 115 0.983
South Sudan 5 0.047
Sudan 49 0.439
Tanzania 103 0.944
Togo 84 0.836
Tunisia 84 0.836
Uganda 100 0.928
Zambia 101 0.934
Zimbabwe 92 0.873
Albania 47 0.433
Argentina 100 0.916
Armenia 47 0.433
Australia 112 0.981
Austria 87 0.848
Bahrain 103 0.955
Bangladesh 108 0.956
Belgium 112 0.983
Bhutan 74 0.736
Bolivia 45 0.425
Bosnia and Herzegovina 47 0.433
Brazil 111 0.975
Cambodia 5 0.033
Canada 114 0.992
Chile 104 0.960
China 114 0.992
Colombia 92 0.901
Costa Rica 103 0.955
Croatia 48 0.443
Czechia 11 0.113
Denmark 101 0.936
Estonia 92 0.901
Finland 107 0.969
France 104 0.929
Georgia 96 0.898
Germany 109 0.977
Greece 103 0.955
Guatemala 10 0.099
Haiti 4 0.028
Hungary 27 0.258
Iceland 92 0.901
India 117 0.996
Indonesia 101 0.931
Iran 103 0.955
Iraq 92 0.901
Ireland 104 0.960
Israel 100 0.921
Italy 108 0.973
Jamaica 4 0.042
Japan 104 0.960
Jordan 108 0.973
Kazakhstan 74 0.736
Kyrgyzstan 89 0.829
Latvia 47 0.433
Lebanon 92 0.901
Lithuania 60 0.524
Luxembourg 92 0.901
Malaysia 99 0.928
Malta 47 0.433
Mexico 112 0.986
Micronesia 92 0.901
Montenegro 47 0.433
Myanmar 84 0.836
Nepal 87 0.820
Netherlands 113 0.985
New Zealand 93 0.906
North Macedonia 47 0.433
Norway 97 0.922
Oman 84 0.836
Pakistan 116 0.994
Panama 87 0.857
Papua New Guinea 92 0.901
Peru 92 0.901
Philippines 93 0.907
Poland 103 0.955
Portugal 93 0.904
Qatar 85 0.837
Romania 98 0.925
Russia 104 0.960
Saudi Arabia 105 0.964
Serbia 103 0.955
Singapore 109 0.977
Slovakia 92 0.901
Slovenia 48 0.442
South Korea 94 0.907
Spain 112 0.982
Sri Lanka 88 0.863
Sweden 105 0.945
Switzerland 112 0.981
Syria 27 0.250
Thailand 64 0.559
Turkey 106 0.943
UK 119 0.997
Ukraine 92 0.901
United Arab Emirates 94 0.909
Uruguay 88 0.858
USA 125 1.000
Vietnam 94 0.908
Yemen 74 0.736
Table 9. Number of universities by country for the whole period.
Table 9. Number of universities by country for the whole period.
Country Universities (nº) Country Universities (nº)
USA 116 Serbia 3
UK 30 Singapore 3
Australia 26 United Arab Emirates 3
Nigeria 23 Algeria 2
China 21 Burkina Faso 2
Ethiopia 20 Cameroon 2
Canada 19 Cote Ivoire 2
Egypt 16 Guatemala 2
India 16 Indonesia 2
Iran 16 Ireland 2
Germany 15 Jordan 2
Italy 15 Lebanon 2
Brazil 14 Lithuania 2
France 12 Malawi 2
South Africa 12 Nepal 2
Saudi Arabia 11 Romania 2
Japan 10 Slovakia 2
Spain 10 Sri Lanka 2
Kenya 9 Zambia 2
Netherlands 9 Albania 1
Tanzania 9 Bahrain 1
Malaysia 7 Benin 1
Sweden 7 Botswana 1
Belgium 6 Costa Rica 1
Pakistan 6 Croatia 1
South Korea 6 Czechia 1
Sudan 6 Estonia 1
Ghana 5 Gabon 1
Philippines 5 Georgia 1
Portugal 5 Greece 1
Switzerland 5 Iceland 1
Turkey 5 Israel 1
Uganda 5 Jamaica 1
Vietnam 5 Kazakhstan 1
Bangladesh 4 Latvia 1
Chile 4 Madagascar 1
Colombia 4 Mali 1
Denmark 4 Mexico 1
Finland 4 Morocco 1
New Zealand 4 Mozambique 1
Norway 4 Papua New Guinea 1
Thailand 4 Qatar 1
Tunisia 4 Rwanda 1
Austria 3 Sierra Leone 1
Dem. Republic of the Congo 3 Slovenia 1
Iraq 3 Syria 1
Libya 3 Togo 1
Poland 3 Uruguay 1
Russia 3 Zimbabwe 1
Table 10. The total number of universities by region, period and respective representativity given the total number of universities in each period.
Table 10. The total number of universities by region, period and respective representativity given the total number of universities in each period.
Period African (nº) Non-African (nº) African (%) Non-African (%)
2000–2019 138 489 22 78
2000–2004 8 11 42 58
2005–2009 25 52 32 68
2010–2014 60 161 27 73
2015–2019 126 446 22 78

Collaboration Networks

Figure 5. Collaboration network given the countries involved in IRC representing the whole period. Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 5059 links. The grey links represent publications between non-African countries, the pink links between African and non-African countries, and the blue links between African countries.
Figure 5. Collaboration network given the countries involved in IRC representing the whole period. Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 5059 links. The grey links represent publications between non-African countries, the pink links between African and non-African countries, and the blue links between African countries.
Preprints 119956 g010
Figure 6. Collaboration subnetwork between African and non-African countries in 2000–2019 (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 1834 links.
Figure 6. Collaboration subnetwork between African and non-African countries in 2000–2019 (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 1834 links.
Preprints 119956 g011
Figure 7. Collaboration subnetwork between African and non-African countries where each link represents two or more publications (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 942 links.
Figure 7. Collaboration subnetwork between African and non-African countries where each link represents two or more publications (the subnetwork derived from Figure 5). Blue nodes represent African countries and grey non-African countries. This network has 129 nodes and 942 links.
Preprints 119956 g012
Figure 8. Collaboration network between universities representing the whole period. The high number of universities does not allow organizing the network in a way that it is possible to identify the university represented in each node. Therefore, the universities are not labelled. Blue nodes represent African universities and grey non-African universities. This network has 627 nodes and 48468 links. The grey links represent publications between non-African universities, the pink links between African and non-African universities, and the blue and green links between African universities.
Figure 8. Collaboration network between universities representing the whole period. The high number of universities does not allow organizing the network in a way that it is possible to identify the university represented in each node. Therefore, the universities are not labelled. Blue nodes represent African universities and grey non-African universities. This network has 627 nodes and 48468 links. The grey links represent publications between non-African universities, the pink links between African and non-African universities, and the blue and green links between African universities.
Preprints 119956 g013
Figure 9. Collaboration subnetwork between African universities (the subnetwork derived from Figure 8). The subnetwork has 138 nodes and 804 links.
Figure 9. Collaboration subnetwork between African universities (the subnetwork derived from Figure 8). The subnetwork has 138 nodes and 804 links.
Preprints 119956 g014
Figure 10. Collaboration subnetwork between African and non-African universities (the subnetwork derived from Figure 8). The subnetwork has 627 nodes and 10409 links.
Figure 10. Collaboration subnetwork between African and non-African universities (the subnetwork derived from Figure 8). The subnetwork has 627 nodes and 10409 links.
Preprints 119956 g015
Table 11. Statistics for the universities in the collaboration network for the whole period.
Table 11. Statistics for the universities in the collaboration network for the whole period.
University Degree Eigencentrality
AAU-DNK 316 0.969
AAU-ETH 319 0.970
ABU-NGA 346 0.978
ABZUMS-IRN 316 0.969
ACU-AUS 258 0.828
AGU-BHR 316 0.969
AGU-ETH 6 0.009
AI-Azar-EGY 2 0.000
AKU-KEN 267 0.833
AKU-PAK 324 0.850
AKU-TZA 3 0.006
Al Neelain-SDN 3 0.000
ALEPUNIV-SYR 22 0.046
Al-Zahar-EGY 4 0.000
AMU-ETH 258 0.828
ANSU-NGA 2 0.003
ANU-AUS 316 0.969
ARU-GBR 316 0.969
ASE-ROM 221 0.695
ASU-EGY 15 0.027
ASU-JOR 41 0.059
ASU-System-USA 258 0.828
Ateneo-PHL 316 0.969
ATSU-USA 221 0.695
AU-AUS 318 0.970
AU-DNK 221 0.695
AU-EGY 4 0.007
AU-ETH 221 0.695
AU-IND 41 0.059
AUMS-IRN 258 0.828
AUN-EGY 24 0.046
AU-SAU 316 0.969
AUT-NZL 331 0.978
AUW-SDN 1 0.003
AYBU-TUR 36 0.065
BCMS-IRQ 258 0.828
BCM-USA 335 0.979
BDU-ETH 318 0.970
BFUHS-IND 258 0.828
BHU-IND 258 0.828
BLDE Univ-IND 16 0.012
BMSU-IRN 316 0.969
BSMMU-BGD 16 0.012
BSMS-GBR 318 0.970
BSU-EGY 3 0.000
BSU-FRA 2 0.004
BSU-USA 221 0.695
BU-EGY 1 0.000
BU-GBR 27 0.053
BU-IND 2 0.004
BUK-NGA 4 0.007
BU-MLI 4 0.007
BU-NGA 1 0.000
BU-UGA 3 0.007
BU-USA 287 0.854
BYU-USA 278 0.850
Cal State-USA 1 0.003
CAM-GBR 270 0.830
CCMU-CHN 127 0.243
CDartmouth-USA 326 0.972
CDU-AUS 60 0.148
CDU-USA 258 0.828
CEU-UCH-ESP 316 0.969
CMU-CHN 9 0.017
CMU-THA 3 0.007
COSECSA-TZA 1 0.000
CPUT-ZAF 1 0.000
CQMU-CHN 41 0.059
CSPH-PAK 316 0.969
CSU-CHN 258 0.828
CTUMP-VNM 1 0.003
CU-CZE 15 0.025
CU-EGY 339 0.973
CUHAS-TZA 9 0.013
CUNY-USA 258 0.828
CUSM-USA 15 0.025
CU-System-USA 273 0.834
CU-THA 41 0.059
CU-USA 366 0.987
CWRU-USA 318 0.970
Dal-CAN 282 0.843
DBU-ETH 316 0.969
DELSU-NGA 3 0.004
DHSC-ETH 1 0.002
DKU-CHN 258 0.828
DMU-ETH 316 0.969
DTU-VNM 316 0.969
DU-AUS 246 0.734
DU-BGD 50 0.070
DU-ETH 221 0.695
DU-GBR 3 0.010
DU-IND 321 0.971
Duke-NUS-SGP 260 0.829
DU-SWE 316 0.969
DUT-ZAF 258 0.828
DU-USA 7 0.011
ECU-AUS 39 0.069
EDU-ETH 5 0.006
Einstein-USA 267 0.830
ENS-ESP 221 0.695
ENSV-DZA 221 0.695
ESUT-NGA 2 0.003
EU-GBR 3 0.004
EU-KEN 10 0.021
EUR-NLD 331 0.978
EU-USA 343 0.982
EVMS-USA 15 0.025
FDU-CHN 342 0.977
FHU-JPN 3 0.004
FOM-DEU 258 0.828
FU-AUS 331 0.978
GMU-USA 331 0.978
GOUMS-IRN 316 0.969
GU-AUS 335 0.980
GU-SDN 2 0.000
GU-SWE 316 0.969
GU-USA 320 0.970
GWU-USA 269 0.834
HBMSU-ARE 316 0.969
HHU-DEU 1 0.000
HKU-CHN 278 0.850
HMU-VNM 316 0.969
HSE Univ-RUS 258 0.828
HU-EGY 8 0.011
HU-ETH 316 0.969
HUJI-ISR 60 0.150
HUST-CHN 1 0.003
HU-TUR 258 0.828
HU-USA 382 0.989
HU-VNM 3 0.007
IMU-MYS 316 0.969
ISCSEM-PRT 221 0.695
ISHIK Univ-IRQ 221 0.695
ISMMS-USA 3 0.007
IUMS-AUS 258 0.828
IUMS-IRN 316 0.969
IU-System-USA 20 0.040
JazanU-SAU 316 0.969
JCU-AUS 278 0.850
Jena Univ-DEU 221 0.695
JHU-USA 374 0.984
JKUAT-KEN 9 0.019
JLU-CHN 41 0.059
JLU-DEU 3 0.004
JMU-DEU 1 0.000
JMU-JPN 4 0.000
JNU-CHN 50 0.076
JSU-USA 316 0.969
JU-ETH 320 0.970
JU-POL 316 0.969
JU-SAU 2 0.000
JUST-JOR 316 0.969
KAU-SAU 3 0.007
KazNMU-KAZ 221 0.695
KBU-TUR 258 0.828
KGMU-IND 258 0.828
KHU-KOR 221 0.695
KI-SWE 345 0.978
KKU-THA 54 0.090
KLE Univ-IND 40 0.056
KMU-IRN 258 0.828
KNUST-GHA 72 0.167
KSAU-HS-SAU 3 0.000
KSU-SAU 319 0.970
KU Leuven-BEL 20 0.031
KU-KEN 4 0.007
KU-KOR 316 0.969
KUMS-IRN 258 0.828
KU-NPL 36 0.065
KU-SDN 2 0.000
KU-TUR 22 0.046
KU-USA 221 0.695
Kyoto U-JPN 221 0.695
LAMU-ZMB 3 0.006
LASU-NGA 18 0.014
LaTrobeU-AUS 223 0.696
LAUTECH-NGA 2 0.000
Lboro-GBR 1 0.004
LCWU-PAK 258 0.828
LEI-NLD 6 0.017
LIMU-LBY 4 0.006
LIU-JPN 221 0.695
Ljubliana UMC-SVN 41 0.059
LMU Munich-DEU 287 0.843
LSMU-LTU 6 0.014
LSU-system-USA 25 0.052
LUC-USA 57 0.147
LU-GBR 3 0.006
LU-SWE 323 0.971
MA-EGY 320 0.970
Mak-UGA 292 0.852
Marburg Univ-DEU 2 0.000
MazUMS-IRN 221 0.695
McGill-CAN 292 0.840
McMaster-CAN 258 0.828
MedUni Vienna-AUT 13 0.022
Minia-EGY 1 0.000
MLU-DEU 221 0.695
MMU-UGA 1 0.003
Mohammed V-MAR 3 0.004
MQ-AUS 4 0.008
MSM-USA 3 0.004
MSU-KEN 5 0.012
MSUMD-RUS 57 0.147
MSU-USA 58 0.147
MTU-ETH 221 0.695
MU-ETH 321 0.970
MUHAS-TZA 343 0.976
MUHS-IND 33 0.059
MU-KEN 54 0.093
MUK-IRN 342 0.977
MUL-POL 41 0.059
MUMS-IRN 221 0.695
MUST-EGY 4 0.000
MUST-MWI 6 0.011
MUST-UGA 3 0.004
MWU-ETH 226 0.699
NCU-JPN 3 0.004
NEU-USA 316 0.969
Newcastle Univ-GBR 258 0.828
NIAID-USA 2 0.000
NJU-CHN 316 0.969
NMCBGK-IND 10 0.014
NMU-JPN 41 0.059
NTU-SGP 221 0.695
NU-GBR 317 0.970
NUIG-IRL 57 0.147
NUS-SGP 357 0.986
NU-System-USA 1 0.001
NU-USA 341 0.981
NWU-ZAF 316 0.969
NYU-USA 262 0.829
OAU-NGA 66 0.084
OHSU-USA 260 0.829
OOU-NGA 3 0.003
OSU-System-USA 265 0.830
OUCRU-VNM 258 0.828
OUHS-IND 16 0.012
OX-GBR 380 0.990
Paris V-FRA 30 0.050
Paris XI-FRA 2 0.000
PHSU-USA 258 0.828
Pitt-USA 316 0.969
PKU-CHN 13 0.031
PolyU-CHN 221 0.695
PSU-USA 9 0.017
PU-IND 1 0.000
PUJ-COL 317 0.970
PU-KEN 6 0.016
Purdue-System-USA 7 0.015
PU-USA 2 0.007
Qom MS-IRN 258 0.828
QU-CAN 2 0.003
QUMS-IRN 221 0.695
QU-SAU 1 0.000
QUT-AUS 316 0.969
Rennes-FRA 4 0.004
RGU-IND 16 0.012
RUDN-RUS 41 0.059
RUG-NLD 322 0.970
RU-ISL 316 0.969
RU-NLD 5 0.010
RUSM-USA 1 0.004
RU-System-USA 17 0.049
RU-USA 9 0.017
Sapienza-ITA 342 0.977
SAUT-TZA 1 0.003
SBUMS-IRN 316 0.969
SCU-EGY 259 0.828
SDU-CHN 41 0.059
SDU-DNK 38 0.069
SFU-CAN 258 0.828
SJSM-GBR 258 0.828
SJTU-CHN 273 0.747
SJU-USA 4 0.000
SKKU-KOR 258 0.828
SLC-CAN 2 0.003
SLU-USA 36 0.065
SMU-BGD 16 0.012
SMU-JPN 7 0.014
SNU-KOR 316 0.969
Southern UC-MYS 258 0.828
SPHMMC-ETH 19 0.050
SRU-IND 316 0.969
St Andrews-GBR 7 0.018
StOlaf-USA 2 0.003
SUE-IRQ 316 0.969
SU-ETH 222 0.695
SUNY-USA 261 0.829
SUSF -USA 321 0.970
SUST-BGD 16 0.012
SU-SWE 259 0.828
SU-USA 266 0.832
SU-ZAF 356 0.979
SUZA-TZA 3 0.004
SYSU-CHN 321 0.970
SZU-CHN 9 0.017
TaibahU-SAU 1 0.003
TAU-FIN 327 0.973
TCNJ-USA 5 0.014
TJU-USA 12 0.029
TNMGRMU-IND 325 0.972
Tor Vergata-ITA 19 0.029
Touro-System-USA 258 0.828
TSMU-GEO 41 0.059
TSU-CHN 3 0.002
TTU-System-USA 3 0.010
TU-EGY 4 0.003
TUMa-TZA 8 0.014
TUMS-IRN 316 0.969
TU-NPL 7 0.013
TUOS-GBR 317 0.970
TU-SAU 3 0.000
TU-SVK 316 0.969
TU-USA 24 0.047
UAB-LBN 8 0.023
UAb-PRT 316 0.969
UAC-BEN 15 0.018
UAEU-ARE 224 0.696
UAlberta-CAN 282 0.838
UAM-ESP 316 0.969
UAM-MEX 227 0.700
UANDES-CHL 18 0.048
UAntwerp-BEL 46 0.068
UA-System-USA 362 0.986
Uautonoma-CHL 258 0.828
UBath-GBR 258 0.828
UB-BWA 5 0.012
UBC-CAN 337 0.979
UB-CHE 362 0.982
UB-ESP 327 0.971
UB-FRA 221 0.695
UB-GBR 9 0.018
UB-LBY 4 0.006
UBordeaux-FRA 6 0.017
UBrandeis-USA 258 0.828
UBrown-USA 285 0.852
UB-SRB 316 0.969
UB-USA 24 0.046
UC Chile-CHL 255 0.714
UCalgary-CAN 338 0.976
UCAR-TUN 4 0.004
UC-AUS 316 0.969
UCC-GHA 321 0.971
UCC-IRL 316 0.969
UCG-ZAR 1 0.001
UChicago-USA 61 0.159
UCLan-GBR 5 0.013
UCM-ESP 12 0.021
UC-NZL 258 0.828
UColgate-USA 258 0.828
UCPEL-BRA 31 0.075
UCPH-DNK 340 0.975
UCP-PRT 221 0.695
UCR-CRI 316 0.969
UC-System-USA 380 0.988
UCT-ZAF 337 0.980
UC-USA 263 0.828
UCU-UGA 3 0.007
UDCA-COL 258 0.828
Udelar-URY 258 0.828
UdeM-CAN 330 0.972
UDESC-BRA 258 0.828
UD-GBR 4 0.000
UDla-CMR 1 0.000
UDOM-TZA 3 0.004
UDP-CHL 4 0.010
UDS-GHA 5 0.007
UDSM-TZA 2 0.000
UD-USA 62 0.161
UDUS-NGA 2 0.000
UEA-GBR 221 0.695
UEF-FIN 3 0.004
UEM-MOZ 66 0.165
UERMMMC-PHL 258 0.828
UEX-ESP 258 0.828
UFAS-DZA 221 0.695
UFBA-BRA 20 0.049
UFC-BRA 7 0.013
UFHB-CIV 6 0.011
UFH-ZAF 1 0.000
UFMG-BRA 319 0.970
UFM-GTM 10 0.014
UFPel-BRA 70 0.143
UFRGS-BRA 316 0.969
UFS-BRA 316 0.969
UFSC-BRA 316 0.969
UGent-BEL 357 0.981
UG-GHA 60 0.121
UG-System-USA 40 0.076
UHAS-GHA 7 0.012
Uhasselt-BEL 18 0.029
UH-FIN 342 0.977
UHoward-USA 333 0.979
UHS Lahore 16 0.012
UHS Lahore-PAK 221 0.695
UH-System-USA 4 0.007
UiB-NOR 349 0.979
UIC-ESP 3 0.004
UIdaho-USA 9 0.018
UI-IDN 20 0.052
UImperial-GBR 360 0.985
UI-NGA 273 0.836
UiO-NOR 321 0.970
UIowa-USA 259 0.828
UiS-NOR 4 0.010
UI-System-USA 258 0.828
UiTM-MYS 2 0.000
UiT-NOR 316 0.969
UJLG-CIV 3 0.004
UKCS-SRB 41 0.059
UKF-SVK 3 0.003
UK-KOR 316 0.969
UKM-MYS 327 0.972
UK-SRB 316 0.969
UKY-USA 6 0.014
UKZN-ZAF 324 0.972
ULancaster-GBR 221 0.695
ULB-BEL 1 0.000
ULeeds-GBR 5 0.017
UL-FRA 316 0.969
UL-GBR 258 0.828
ULisboa-PRT 221 0.695
UL-LVA 41 0.059
Ulm-DEU 316 0.969
UL-TGO 258 0.828
UManitoba-CAN 316 0.969
UMass-System-USA 318 0.970
UM-AUS 253 0.741
UMDNJ-USA 17 0.029
UM-EGY 3 0.000
UMFCD-ROM 316 0.969
UMGA-MDG 1 0.000
UM-GBR 41 0.076
UMG-USA 15 0.025
UMiami-USA 57 0.147
UMich-System-USA 30 0.064
UMIT TIROL-AUT 258 0.828
UM-MYS 6 0.007
UM-NLD 5 0.007
UMontpellier-FRA 4 0.004
UMSHA-IRN 221 0.695
UM-System-USA 278 0.850
UMT-ALB 41 0.059
UM-THA 32 0.079
UMT-PAK 316 0.969
UM-TUN 5 0.004
UM-TUR 20 0.049
UM-USA 316 0.969
UMU-SWE 3 0.010
UNAL-COL 316 0.969
UNB-BFA 1 0.000
UnB-BRA 258 0.828
UNC-System-USA 367 0.984
Uni Bielefeld-DEU 316 0.969
Uni Freiburg-DEU 44 0.060
Uni Heidelberg-DEU 319 0.970
Uni Hohenheim-DEU 318 0.970
Uni Tubingen-DEU 43 0.073
UNIABUJA-NGA 17 0.014
UniBa-ITA 316 0.969
UNIBEN-NGA 21 0.023
UNIBO-ITA 316 0.969
UNICA-ITA 18 0.029
UNICAL-NGA 4 0.004
UNICAMP-BRA 36 0.065
UNICARTAGENA-COL 316 0.969
UNIFESP-BRA 49 0.086
UNIFI-ITA 31 0.067
UNIFR-CHE 2 0.000
UNIGE-CHE 3 0.003
UNIJOS-NGA 12 0.017
UNIKIN-ZAR 254 0.721
UNILAG-NGA 228 0.702
UNIL-CHE 18 0.029
UNILIM-FRA 2 0.000
UNILORIN-NGA 20 0.015
UNILU-ZAR 3 0.003
UNIMAID-NGA 4 0.004
UNIMA-MWI 85 0.161
UNIMED-NGA 2 0.000
UniME-ITA 18 0.029
UNIMELB-AUS 339 0.980
UNIMI-ITA 353 0.979
UniofExter-GBR 2 0.004
UniOulu -FIN 3 0.007
UniPD-ITA 3 0.010
UNIPG-ITA 41 0.059
UNIPORT-NGA 4 0.004
UNIPR-ITA 18 0.029
UNIPV-ITA 22 0.046
UniSA-AUS 261 0.831
UNISA-ITA 316 0.969
UNISA-ZAF 57 0.147
UNIST-HRV 6 0.014
UNISTRA-FRA 2 0.000
UNISUL-BRA 258 0.828
UniTo-ITA 30 0.056
UniTS-ITA 1 0.003
UNIVEN-ZAF 7 0.013
UNIZIK-NGA 3 0.004
UNM-USA 323 0.971
UNNES-IDN 221 0.695
UNN-NGA 225 0.702
UNSW-AUS 333 0.978
UNZA-ZMB 325 0.971
UoA-NZL 338 0.980
UO-BFA 1 0.003
UOB-LBN 2 0.004
UoC-DEU 1 0.000
UoC-LKA 258 0.828
UOEH-JPN 316 0.969
UofA-System-USA 3 0.003
UofA-USA 318 0.970
UofG-CAN 2 0.006
UofG-SDN 22 0.046
UofK-SDN 37 0.065
UofL-USA 266 0.832
UofM-System-USA 14 0.019
UoG-ETH 319 0.970
UOH-SAU 221 0.695
UoL-GBR 433 1.000
UoN-KEN 335 0.972
UO-NZL 278 0.850
UO-System-USA 336 0.974
UOT-LBY 22 0.046
uOttawa-CAN 317 0.969
UOW-AUS 1 0.003
UPenn-USA 285 0.853
UPeradeniya-LKA 278 0.850
UPF-ESP 258 0.828
UPMC-FRA 6 0.004
UPMC-USA 5 0.014
UPM-PHL 221 0.695
UPNG -PNG 316 0.969
UP-PHL 258 0.828
UP-PRT 320 0.971
UP-ZAF 37 0.072
UQ-AUS 337 0.980
UQU-SAU 2 0.000
URC-USA 36 0.065
URI-USA 260 0.829
URochester-USA 4 0.007
UR-RWA 8 0.012
UR-USA 36 0.065
URV-ESP 18 0.029
USAC-GTM 12 0.023
uSask -CAN 221 0.695
USA-USA 15 0.025
USC-PHL 24 0.062
USC-System-USA 7 0.017
US-GBR 348 0.979
USG-USA 3 0.007
USL-SLE 22 0.046
USM-MYS 316 0.969
USM-System-USA 32 0.069
USO-TUN 4 0.004
USP-BRA 352 0.979
USS-GAB 7 0.004
US-USA 221 0.695
USYD-AUS 331 0.978
UTAS-AUS 258 0.828
UTennessee-System-USA 344 0.978
UT-EST 221 0.695
UTH-GRC 248 0.706
UTM-TUN 7 0.007
Utokyo-JPN 246 0.734
UToronto-CAN 352 0.979
UTS-AUS 37 0.065
UT-System-USA 248 0.737
UT-USA 319 0.970
UU-IND 221 0.695
UU-NLD 44 0.080
UU-SWE 323 0.972
UU-USA 258 0.828
UvA-NLD 10 0.011
UVA-USA 333 0.972
UV-ESP 316 0.969
UVSQ-FRA 3 0.000
UW System-USA 2 0.003
UWA-AUS 344 0.981
UWC-ZAF 3 0.006
UWE-GBR 258 0.828
UW-GBR 317 0.970
UWI-JAM 7 0.015
UWK-AUT 258 0.828
UW-KEN 3 0.010
UWO-CAN 258 0.828
UWS-AUS 316 0.969
UW-USA 384 0.990
UYI-CMR 4 0.007
UZ Brussel-BEL 41 0.059
UZH-CHE 269 0.830
UZ-ZWE 33 0.079
Vandy-USA 62 0.157
VCU-USA 316 0.969
Virginia Tech-USA 258 0.828
VU Amsterdam-NLD 25 0.049
VU-CAN 4 0.006
VU-LTU 41 0.059
WAIT-AUS 316 0.969
WaldenU-USA 261 0.829
WCM-Q-QAT 258 0.828
WCRI-CAN 6 0.017
WFU-USA 58 0.151
Wits Univ-ZAF 375 0.988
WKU-USA 6 0.014
WMU-CHN 41 0.059
WMU-POL 316 0.969
WSU-ETH 15 0.040
WSU-System -USA 9 0.018
WSU-USA 261 0.828
WU-ETH 221 0.695
WUR-NLD 316 0.969
WUSTL-USA 221 0.695
WVU System-USA 2 0.003
XJTU-CHN 23 0.059
XMU-MYS 221 0.695
YCU-JPN 221 0.695
York Univ-CAN 3 0.003
York Univ-GBR 260 0.829
YU-KOR 316 0.969
YU-USA 351 0.984
ZJU-CHN 62 0.101
ZU-ARE 2 0.000
ZU-EGY 4 0.000
ZUMS-IRN 221 0.695
Table 12. Impact of the articles according to the type of collaboration and period of publication. Note: for several periods, the number of articles is below 20 (see Table 5 above).
Table 12. Impact of the articles according to the type of collaboration and period of publication. Note: for several periods, the number of articles is below 20 (see Table 5 above).
Period CNCI (median)
DRC IRC no_coll
2000–2019 0.504 1.083 0.300
2000–2004 0.467 0.673 0.299
2005–2009 0.468 1.061 0.000
2010–2014 0.514 1.272 0.349
2015–2019 0.500 1.038 0.206
Table 13. Impact of the articles according to the different types of IRC and period of publication. Note: for several periods, the number of articles is below 20.
Table 13. Impact of the articles according to the different types of IRC and period of publication. Note: for several periods, the number of articles is below 20.
Period CNCI (median)
IRCintra IRCinter IRCinter_intra
2000–2019 0.724 1.012 1.369
2000–2004 0.000 0.673 1.371
2005–2009 0.264 1.009 1.624
2010–2014 0.479 1.225 1.913
2015–2019 0.783 0.981 1.265
Table 14. The number of articles with research collaboration by topic and period.
Table 14. The number of articles with research collaboration by topic and period.
Micro-Topic Pub (nº)
2000–2019 2000–2004 2005–2009 2010–2014 2015–2019
1.156.381 Maternal Mortality 191 6 21 57 107
1.23.1757 Group B Streptococcus 125 8 9 28 80
1.117.1389 Bilirubin 91 1 8 24 58
1.72.182 Gestational Diabetes Mellitus 88 3 7 24 54
1.72.924 Preterm Labor 64 2 6 11 45
1.72.531 Preeclampsia 58 3 9 10 36
1.66.11 HIV Prevalence & Prophylaxis 49 1 5 12 31
1.217.59 Malaria 39 1 6 15 17
1.72.922 Fetal Heart Rate 37 0 9 6 22
1.72.1732 Patent Ductus Arteriosus 25 3 1 9 12
1.72.748 Preterm Infants 23 0 1 9 13
1.23.146 Antibiotic Resistance 21 0 1 3 17
1.44.1198 Food Insecurity 19 0 0 9 10
1.216.2287 Gastroschisis 18 1 2 1 14
1.72.808 Breech Presentation 17 1 1 1 14
1.184.573 Iron Overload 13 1 1 4 7
1.248.655 Chlamydia Trachomatis 13 0 2 1 10
1.72.891 Breastfeeding 12 1 2 2 7
1.125.1718 Hepatitis E Virus 11 2 3 1 5
1.72.1072 Postpartum Depression 11 0 1 1 9
1.80.279 Vitamin D 11 0 1 0 10
1.225.2074 Methemoglobinemia 10 0 0 6 4
1.49.468 Oral Health 10 0 0 2 8
1.154.1057 Pulmonary Surfactant 8 0 2 2 4
1.156.2047 Global Surgery 8 0 1 2 5
1.157.728 Biliary Atresia 8 1 1 1 5
1.75.326 Antiphospholipid Syndrome 8 0 1 4 3
1.81.979 Twin-Twin Transfusion Syndrome 7 0 1 3 3
8.124.552 Air Pollution 7 0 0 1 6
1.150.1148 Deaf 6 0 3 0 3
1.55.830 Acute Kidney Injury 6 0 2 0 4
1.120.384 Gut Microbiota 5 0 0 2 3
1.148.94 Candida Albicans 5 0 0 2 3
1.151.222 Laparoscopic Cholecystectomy 5 0 0 0 5
1.225.626 Sickle Cell Disease 5 0 0 1 4
1.103.1225 ITP 4 0 1 3 0
1.104.975 Respiratory Syncytial Virus 4 1 0 1 2
1.137.217 Melatonin 4 0 0 0 4
1.154.360 Procalcitonin 4 0 0 1 3
1.23.173 Staphylococcus Aureus 4 0 0 0 4
1.42.678 Listeria Monocytogenes 4 1 1 0 2
1.82.1066 Cerebral Palsy 4 0 0 3 1
1.104.126 Influenza 3 0 0 1 2
1.125.275 HBV 3 0 0 0 3
1.128.482 Contraception 3 0 0 0 3
1.161.711 Cytomegalovirus 3 0 1 1 1
1.194.273 Mycobacterium Tuberculosis & Leprosy 3 0 0 1 2
1.216.1563 Volvulus 3 0 0 0 3
1.216.1996 Pneumomediastinum 3 0 0 1 2
1.231.432 Homocysteine 3 1 0 1 1
1.248.1317 Mycoplasma 3 0 0 2 1
1.248.2104 Trichomonas Vaginalis 3 1 0 1 1
1.257.983 Hydrocephalus 3 0 0 2 1
1.37.309 Congenital Heart Disease 3 0 0 1 2
1.72.1745 Hyperemesis Gravidarum 3 0 0 2 1
1.95.723 Irritable Bowel Syndrome 3 0 2 1 0
3.91.920 Selenium 3 0 1 0 2
6.24.858 Intimate Partner Violence 3 0 0 1 2
1.125.83 HCV 2 1 1 0 0
1.141.407 Acute Promyelocytic Leukemia 2 1 0 0 1
1.161.315 HSV-1 2 0 0 2 0
1.222.143 Epilepsy 2 0 1 1 0
1.228.994 Ebola Virus 2 0 0 0 2
1.23.1036 Surgical Site Infection 2 1 0 0 1
1.23.422 Gentamicin 2 0 0 1 1
1.235.1679 Foreign Body 2 0 0 0 2
1.258.1958 Leptospirosis 2 0 0 0 2
1.286.845 Complement 2 0 1 0 1
1.42.545 STEC 2 0 0 0 2
1.6.351 Endotoxin 2 0 0 1 1
1.81.1272 HLA-G 2 0 0 0 2
1.81.1408 Fertility Preservation 2 0 0 1 1
4.61.1124 Rough Sets 2 0 0 1 1
6.178.516 Divorce 2 0 0 0 2
1.100.1284 Fetal Alcohol Syndrome 1 0 0 0 1
1.104.1770 Pertussis 1 0 0 0 1
1.104.901 Foot-And-Mouth Disease Virus 1 0 0 0 1
1.105.1677 Vertebral Artery Dissection 1 0 0 1 0
1.111.162 Hepatocellular Carcinoma 1 1 0 0 0
1.117.1309 Acetaminophen 1 0 0 1 0
1.127.1303 Endothelin 1 0 0 1 0
1.128.1489 Hysteroscopy 1 0 0 0 1
1.128.1521 Ectopic Pregnancy 1 0 0 0 1
1.132.2267 Clubfoot 1 0 0 0 1
1.132.759 Matrix Metalloproteinases 1 0 1 0 0
1.136.1749 Down Syndrome 1 0 0 0 1
1.136.1780 Family Quality Of Life 1 0 0 0 1
1.136.283 Autism 1 0 0 0 1
1.14.1293 Emergency Department 1 0 0 0 1
1.14.1359 Interprofessional Education 1 0 0 0 1
1.142.1628 Urinary Diversion 1 1 0 0 0
1.142.832 Fecal Incontinence 1 0 0 0 1
1.154.1088 Intensive Care 1 0 0 0 1
1.154.277 Mechanical Ventilation 1 0 0 0 1
1.155.598 Informed Consent 1 0 0 0 1
1.158.2138 Porokeratosis 1 0 0 0 1
1.163.446 Schistosomiasis 1 0 0 0 1
1.164.1871 Menarche 1 0 0 0 1
1.168.671 Vascular Access 1 0 0 1 0
1.179.108 Human Papillomavirus 1 0 0 0 1
1.184.1030 Erythropoietin 1 1 0 0 0
1.184.653 Zinc 1 0 0 0 1
1.186.1008 Nuchal Translucency 1 0 0 0 1
1.186.948 Digeorge Syndrome 1 0 0 0 1
1.195.1341 Enteric Nervous System 1 1 0 0 0
1.199.1048 Pleurodesis 1 1 0 0 0
1.213.168 Hypothyroidism 1 0 0 1 0
1.216.2098 Intussusception 1 0 1 0 0
1.217.1038 Toxoplasma Gondii 1 0 0 1 0
1.225.1476 Alloimmunization 1 0 0 0 1
1.225.786 Spectrin 1 0 0 0 1
1.228.200 Dengue 1 0 0 0 1
1.23.1397 Urinary Tract Infection 1 0 0 0 1
1.23.714 Neisseria Meningitidis 1 0 0 0 1
1.235.1617 Deglutition 1 0 0 0 1
1.236.1155 Capsule Endoscopy 1 0 0 1 0
1.236.312 Portal Hypertension 1 0 0 0 1
1.243.1012 Vesicoureteral Reflux 1 0 0 1 0
1.246.710 Rotavirus 1 1 0 0 0
1.258.227 Lyme Disease 1 0 0 1 0
1.26.107 Adiponectin 1 0 0 0 1
1.26.337 Leptin 1 0 1 0 0
1.261.596 Trypanosoma Cruzi 1 0 1 0 0
1.266.1068 Pressure Ulcer 1 0 0 0 1
1.278.1796 Neuroblastoma 1 0 0 1 0
1.281.1236 Amyloidosis 1 0 0 1 0
1.324.2020 Tetanus 1 0 1 0 0
1.34.1657 Elbow 1 0 0 1 0
1.36.2059 Retinopathy Of Prematurity 1 0 0 0 1
1.37.467 Echocardiography 1 0 0 1 0
1.49.1061 Endodontics 1 0 0 0 1
1.5.1674 Ketogenic Diet 1 0 1 0 0
1.5.420 Cortisol 1 0 0 0 1
1.54.1401 Genome Editing 1 0 0 1 0
1.54.958 HMGB1 1 0 1 0 0
1.55.1904 ACE Gene 1 0 0 0 1
1.6.452 Somatic Hypermutation 1 0 0 0 1
1.6.609 Toll-like Receptors 1 0 0 0 1
1.65.192 COPD 1 0 0 1 0
1.66.1615 Aids Dementia Complex 1 0 0 0 1
1.68.256 Docosahexaenoic Acid 1 0 0 0 1
1.68.707 Alpha-Tocopherol 1 0 1 0 0
1.71.2048 Mean Platelet Volume 1 0 0 0 1
1.72.1710 Postpartum Hemorrhage 1 0 0 0 1
1.82.1298 Spinal Cord Injury Rehabilitation 1 0 0 0 1
1.94.1664 VKORC1 1 1 0 0 0
1.95.387 Helicobacter Pylori 1 0 0 0 1
1.95.801 Cimetidine 1 0 0 1 0
3.16.1496 Ethnobotany 1 0 0 0 1
3.171.1011 Carotenoids 1 0 0 0 1
3.180.2418 Alginate Lyase 1 0 0 0 1
3.198.400 Mycotoxins 1 0 0 1 0
3.91.496 Cadmium 1 0 0 0 1
6.146.734 Anthropology 1 0 0 0 1
6.73.2331 Health Locus of Control 1 0 0 0 1
8.124.1648 Heat Waves 1 0 0 0 1
Table 15. The number of articles by topic and type of collaboration for the whole period.
Table 15. The number of articles by topic and type of collaboration for the whole period.
Micro-Topic Collaboration Pub (nº) Micro-Topic Collaboration Pub (nº)
1.100.1284 Fetal Alcohol Syndrome DRC 1 1.231.1650 Thiamine no_coll 1
1.103.1225 ITP DRC 2 1.231.432 Homocysteine DRC 1
1.103.1225 ITP IRC 2 1.231.432 Homocysteine IRC 2
1.104.126 Influenza DRC 1 1.235.1617 Deglutition DRC 1
1.104.126 Influenza IRC 2 1.235.1679 Foreign Body IRC 2
1.104.1770 Pertussis IRC 1 1.236.1155 Capsule Endoscopy DRC 1
1.104.901 Foot-And-Mouth Disease Virus IRC 1 1.236.312 Portal Hypertension DRC 1
1.104.975 Respiratory Syncytial Virus DRC 1 1.243.1012 Vesicoureteral Reflux DRC 1
1.104.975 Respiratory Syncytial Virus IRC 3 1.246.710 Rotavirus DRC 1
1.105.1677 Vertebral Artery Dissection DRC 1 1.248.1317 Mycoplasma DRC 2
1.111.162 Hepatocellular Carcinoma DRC 1 1.248.1317 Mycoplasma IRC 1
1.117.1309 Acetaminophen DRC 1 1.248.1683 Syphilis no_coll 1
1.117.1389 Bilirubin DRC 57 1.248.2104 Trichomonas Vaginalis IRC 3
1.117.1389 Bilirubin IRC 34 1.248.655 Chlamydia Trachomatis DRC 4
1.120.384 Gut Microbiota DRC 2 1.248.655 Chlamydia Trachomatis IRC 9
1.120.384 Gut Microbiota IRC 3 1.257.983 Hydrocephalus IRC 3
1.120.384 Gut Microbiota no_coll 1 1.258.1958 Leptospirosis IRC 2
1.125.1718 Hepatitis E Virus DRC 2 1.258.227 Lyme Disease IRC 1
1.125.1718 Hepatitis E Virus IRC 9 1.26.107 Adiponectin DRC 1
1.125.275 HBV DRC 2 1.26.337 Leptin DRC 1
1.125.275 HBV IRC 1 1.261.596 Trypanosoma Cruzi DRC 1
1.125.83 HCV DRC 1 1.266.1068 Pressure Ulcer IRC 1
1.125.83 HCV IRC 1 1.278.1796 Neuroblastoma DRC 1
1.127.1303 Endothelin IRC 1 1.281.1236 Amyloidosis IRC 1
1.128.1489 Hysteroscopy DRC 1 1.286.845 Complement DRC 1
1.128.1521 Ectopic Pregnancy DRC 1 1.286.845 Complement IRC 1
1.128.482 Contraception DRC 1 1.324.2020 Tetanus DRC 1
1.128.482 Contraception IRC 2 1.34.1657 Elbow DRC 1
1.132.2267 Clubfoot IRC 1 1.36.2059 Retinopathy Of Prematurity DRC 1
1.132.759 Matrix Metalloproteinases DRC 1 1.37.309 Congenital Heart Disease DRC 1
1.136.1749 Down Syndrome DRC 1 1.37.309 Congenital Heart Disease IRC 2
1.136.1780 Family Quality Of Life IRC 1 1.37.467 Echocardiography DRC 1
1.136.283 Autism DRC 1 1.42.545 STEC DRC 1
1.137.217 Melatonin DRC 3 1.42.545 STEC IRC 1
1.137.217 Melatonin IRC 1 1.42.678 Listeria Monocytogenes DRC 3
1.14.1293 Emergency Department IRC 1 1.42.678 Listeria Monocytogenes IRC 1
1.14.1359 Interprofessional Education DRC 1 1.44.1198 Food Insecurity DRC 1
1.141.407 Acute Promyelocytic Leukemia DRC 1 1.44.1198 Food Insecurity IRC 18
1.141.407 Acute Promyelocytic Leukemia IRC 1 1.49.1061 Endodontics IRC 1
1.142.1628 Urinary Diversion DRC 1 1.49.468 Oral Health DRC 5
1.142.832 Fecal Incontinence DRC 1 1.49.468 Oral Health IRC 5
1.142.832 Fecal Incontinence no_coll 1 1.5.1674 Ketogenic Diet DRC 1
1.148.94 Candida Albicans DRC 4 1.5.420 Cortisol IRC 1
1.148.94 Candida Albicans IRC 1 1.54.1401 Genome Editing IRC 1
1.150.1148 Deaf DRC 5 1.54.958 HMGB1 IRC 1
1.150.1148 Deaf IRC 1 1.55.1904 ACE Gene DRC 1
1.150.1148 Deaf no_coll 2 1.55.830 Acute Kidney Injury DRC 6
1.151.222 Laparoscopic Cholecystectomy DRC 4 1.6.1437 Common Variable Immunodeficiency no_coll 1
1.151.222 Laparoscopic Cholecystectomy IRC 1 1.6.351 Endotoxin DRC 1
1.154.1057 Pulmonary Surfactant DRC 2 1.6.351 Endotoxin IRC 1
1.154.1057 Pulmonary Surfactant IRC 6 1.6.452 Somatic Hypermutation DRC 1
1.154.1057 Pulmonary Surfactant no_coll 1 1.6.609 Toll-like Receptors DRC 1
1.154.1088 Intensive Care DRC 1 1.65.192 COPD IRC 1
1.154.277 Mechanical Ventilation DRC 1 1.66.11 HIV Prevalence & Prophylaxis DRC 12
1.154.360 Procalcitonin DRC 1 1.66.11 HIV Prevalence & Prophylaxis IRC 37
1.154.360 Procalcitonin IRC 3 1.66.1615 Aids Dementia Complex IRC 1
1.155.598 Informed Consent IRC 1 1.68.256 Docosahexaenoic Acid DRC 1
1.156.2047 Global Surgery DRC 1 1.68.707 Alpha-Tocopherol IRC 1
1.156.2047 Global Surgery IRC 7 1.71.2048 Mean Platelet Volume DRC 1
1.156.381 Maternal Mortality DRC 47 1.72.1072 Postpartum Depression DRC 2
1.156.381 Maternal Mortality IRC 144 1.72.1072 Postpartum Depression IRC 9
1.156.381 Maternal Mortality no_coll 3 1.72.1710 Postpartum Hemorrhage DRC 1
1.157.728 Biliary Atresia DRC 8 1.72.1732 Patent Ductus Arteriosus DRC 21
1.158.2138 Porokeratosis DRC 1 1.72.1732 Patent Ductus Arteriosus IRC 4
1.161.315 HSV-1 IRC 2 1.72.1745 Hyperemesis Gravidarum DRC 2
1.161.711 Cytomegalovirus DRC 2 1.72.1745 Hyperemesis Gravidarum IRC 1
1.161.711 Cytomegalovirus IRC 1 1.72.182 Gestational Diabetes Mellitus DRC 23
1.161.711 Cytomegalovirus no_coll 1 1.72.182 Gestational Diabetes Mellitus IRC 65
1.163.446 Schistosomiasis IRC 1 1.72.182 Gestational Diabetes Mellitus no_coll 2
1.164.1871 Menarche DRC 1 1.72.531 Preeclampsia DRC 36
1.168.671 Vascular Access DRC 1 1.72.531 Preeclampsia IRC 22
1.179.108 Human Papillomavirus IRC 1 1.72.531 Preeclampsia no_coll 2
1.184.1030 Erythropoietin DRC 1 1.72.748 Preterm Infants DRC 10
1.184.573 Iron Overload IRC 13 1.72.748 Preterm Infants IRC 13
1.184.653 Zinc DRC 1 1.72.808 Breech Presentation DRC 9
1.186.1008 Nuchal Translucency DRC 1 1.72.808 Breech Presentation IRC 8
1.186.948 Digeorge Syndrome DRC 1 1.72.891 Breastfeeding DRC 7
1.194.273 Mycobacterium Tuberculosis & Leprosy DRC 1 1.72.891 Breastfeeding IRC 5
1.194.273 Mycobacterium Tuberculosis & Leprosy IRC 2 1.72.922 Fetal Heart Rate DRC 18
1.195.1341 Enteric Nervous System DRC 1 1.72.922 Fetal Heart Rate IRC 19
1.199.1048 Pleurodesis DRC 1 1.72.922 Fetal Heart Rate no_coll 1
1.213.168 Hypothyroidism DRC 1 1.72.924 Preterm Labor DRC 34
1.216.1563 Volvulus DRC 1 1.72.924 Preterm Labor IRC 30
1.216.1563 Volvulus IRC 2 1.75.326 Antiphospholipid Syndrome DRC 7
1.216.1996 Pneumomediastinum DRC 3 1.75.326 Antiphospholipid Syndrome IRC 1
1.216.2098 Intussusception DRC 1 1.80.279 Vitamin D DRC 6
1.216.2287 Gastroschisis DRC 12 1.80.279 Vitamin D IRC 5
1.216.2287 Gastroschisis IRC 6 1.81.1272 HLA-G DRC 2
1.216.2287 Gastroschisis no_coll 2 1.81.1408 Fertility Preservation DRC 2
1.217.1038 Toxoplasma Gondii IRC 1 1.81.979 Twin-Twin Transfusion Syndrome DRC 5
1.217.59 Malaria DRC 11 1.81.979 Twin-Twin Transfusion Syndrome IRC 2
1.217.59 Malaria IRC 28 1.81.979 Twin-Twin Transfusion Syndrome no_coll 1
1.217.59 Malaria no_coll 1 1.82.1066 Cerebral Palsy DRC 3
1.222.143 Epilepsy IRC 2 1.82.1066 Cerebral Palsy IRC 1
1.222.143 Epilepsy no_coll 1 1.82.1298 Spinal Cord Injury Rehabilitation IRC 1
1.225.1476 Alloimmunization DRC 1 1.94.1664 VKORC1 DRC 1
1.225.2074 Methemoglobinemia DRC 5 1.95.387 Helicobacter Pylori DRC 1
1.225.2074 Methemoglobinemia IRC 5 1.95.723 Irritable Bowel Syndrome DRC 2
1.225.626 Sickle Cell Disease DRC 4 1.95.723 Irritable Bowel Syndrome IRC 1
1.225.626 Sickle Cell Disease IRC 1 1.95.801 Cimetidine IRC 1
1.225.786 Spectrin DRC 1 3.16.1496 Ethnobotany DRC 1
1.228.200 Dengue DRC 1 3.171.1011 Carotenoids DRC 1
1.228.200 Dengue no_coll 1 3.180.2418 Alginate Lyase DRC 1
1.228.994 Ebola Virus DRC 1 3.198.400 Mycotoxins IRC 1
1.228.994 Ebola Virus IRC 1 3.91.496 Cadmium DRC 1
1.23.1036 Surgical Site Infection DRC 2 3.91.920 Selenium DRC 1
1.23.1397 Urinary Tract Infection DRC 1 3.91.920 Selenium IRC 2
1.23.146 Antibiotic Resistance DRC 5 4.61.1124 Rough Sets IRC 2
1.23.146 Antibiotic Resistance IRC 16 6.146.734 Anthropology IRC 1
1.23.173 Staphylococcus Aureus DRC 1 6.178.516 Divorce IRC 2
1.23.173 Staphylococcus Aureus IRC 3 6.24.858 Intimate Partner Violence DRC 1
1.23.1757 Group B Streptococcus DRC 72 6.24.858 Intimate Partner Violence IRC 2
1.23.1757 Group B Streptococcus IRC 53 6.73.2331 Health Locus of Control IRC 1
1.23.1757 Group B Streptococcus no_coll 3 8.124.1648 Heat Waves IRC 1
1.23.422 Gentamicin DRC 1 8.124.552 Air Pollution DRC 4
1.23.422 Gentamicin IRC 1 8.124.552 Air Pollution IRC 3
1.23.714 Neisseria Meningitidis DRC 1
Table 16. Impact of the articles by topic and type of collaboration for the full period. Note: For various topics, the total number of articles is below 20.
Table 16. Impact of the articles by topic and type of collaboration for the full period. Note: For various topics, the total number of articles is below 20.
Topic Collaboration CNCI (median)
1.100.1284 Fetal Alcohol Syndrome DRC 1.536
1.103.1225 ITP DRC 0.318
1.103.1225 ITP IRC 0.227
1.104.126 Influenza DRC 0.225
1.104.126 Influenza IRC 4.503
1.104.1770 Pertussis IRC 0.924
1.104.901 Foot-And-Mouth Disease Virus IRC 1.438
1.104.975 Respiratory Syncytial Virus DRC 0.000
1.104.975 Respiratory Syncytial Virus IRC 1.675
1.105.1677 Vertebral Artery Dissection DRC 0.978
1.111.162 Hepatocellular Carcinoma DRC 0.197
1.117.1309 Acetaminophen DRC 0.178
1.117.1389 Bilirubin DRC 0.554
1.117.1389 Bilirubin IRC 1.561
1.120.384 Gut Microbiota DRC 0.224
1.120.384 Gut Microbiota IRC 1.265
1.125.1718 Hepatitis E Virus DRC 0.384
1.125.1718 Hepatitis E Virus IRC 1.062
1.125.275 HBV DRC 0.129
1.125.275 HBV IRC 0.000
1.125.83 HCV DRC 0.546
1.125.83 HCV IRC 1.320
1.127.1303 Endothelin IRC 0.810
1.128.1489 Hysteroscopy DRC 0.287
1.128.1521 Ectopic Pregnancy DRC 3.365
1.128.482 Contraception DRC 0.315
1.128.482 Contraception IRC 0.204
1.132.2267 Clubfoot IRC 1.649
1.132.759 Matrix Metalloproteinases DRC 1.198
1.136.1749 Down Syndrome DRC 0.225
1.136.1780 Family Quality Of Life IRC 0.931
1.136.283 Autism DRC 0.301
1.137.217 Melatonin DRC 0.799
1.137.217 Melatonin IRC 0.253
1.14.1293 Emergency Department IRC 0.192
1.14.1359 Interprofessional Education DRC 0.637
1.141.407 Acute Promyelocytic Leukemia DRC 2.227
1.141.407 Acute Promyelocytic Leukemia IRC 0.278
1.142.1628 Urinary Diversion DRC 0.965
1.142.832 Fecal Incontinence DRC 2.110
1.148.94 Candida Albicans DRC 0.736
1.148.94 Candida Albicans IRC 1.067
1.150.1148 Deaf DRC 0.848
1.150.1148 Deaf IRC 0.854
1.151.222 Laparoscopic Cholecystectomy DRC 0.029
1.151.222 Laparoscopic Cholecystectomy IRC 0.193
1.154.1057 Pulmonary Surfactant DRC 0.138
1.154.1057 Pulmonary Surfactant IRC 0.548
1.154.1088 Intensive Care DRC 0.144
1.154.277 Mechanical Ventilation DRC 0.037
1.154.360 Procalcitonin DRC 1.875
1.154.360 Procalcitonin IRC 0.656
1.155.598 Informed Consent IRC 0.495
1.156.2047 Global Surgery DRC 0.409
1.156.2047 Global Surgery IRC 1.760
1.156.381 Maternal Mortality DRC 0.518
1.156.381 Maternal Mortality IRC 1.059
1.157.728 Biliary Atresia DRC 0.279
1.158.2138 Porokeratosis DRC 1.291
1.161.315 HSV-1 IRC 0.625
1.161.711 Cytomegalovirus DRC 0.095
1.161.711 Cytomegalovirus IRC 2.382
1.163.446 Schistosomiasis IRC 2.650
1.164.1871 Menarche DRC 0.271
1.168.671 Vascular Access DRC 0.337
1.179.108 Human Papillomavirus IRC 0.776
1.184.1030 Erythropoietin DRC 0.056
1.184.573 Iron Overload IRC 1.267
1.184.653 Zinc DRC 1.264
1.186.1008 Nuchal Translucency DRC 1.270
1.186.948 Digeorge Syndrome DRC 0.070
1.194.273 Mycobacterium Tuberculosis & Leprosy DRC 0.757
1.194.273 Mycobacterium Tuberculosis & Leprosy IRC 7.416
1.195.1341 Enteric Nervous System DRC 0.590
1.199.1048 Pleurodesis DRC 0.857
1.213.168 Hypothyroidism DRC 0.000
1.216.1563 Volvulus DRC 1.147
1.216.1563 Volvulus IRC 0.895
1.216.1996 Pneumomediastinum DRC 0.266
1.216.2098 Intussusception DRC 0.134
1.216.2287 Gastroschisis DRC 0.546
1.216.2287 Gastroschisis IRC 1.876
1.217.1038 Toxoplasma Gondii IRC 0.755
1.217.59 Malaria DRC 0.491
1.217.59 Malaria IRC 1.331
1.222.143 Epilepsy IRC 1.278
1.225.1476 Alloimmunization DRC 0.492
1.225.2074 Methemoglobinemia DRC 0.851
1.225.2074 Methemoglobinemia IRC 1.007
1.225.626 Sickle Cell Disease DRC 0.330
1.225.626 Sickle Cell Disease IRC 1.752
1.225.786 Spectrin DRC 0.000
1.228.200 Dengue DRC 1.134
1.228.994 Ebola Virus DRC 0.165
1.228.994 Ebola Virus IRC 0.495
1.23.1036 Surgical Site Infection DRC 0.355
1.23.1397 Urinary Tract Infection DRC 0.704
1.23.146 Antibiotic Resistance DRC 0.621
1.23.146 Antibiotic Resistance IRC 1.050
1.23.173 Staphylococcus Aureus DRC 0.223
1.23.173 Staphylococcus Aureus IRC 0.521
1.23.1757 Group B Streptococcus DRC 0.790
1.23.1757 Group B Streptococcus IRC 0.878
1.23.422 Gentamicin DRC 0.628
1.23.422 Gentamicin IRC 0.401
1.23.714 Neisseria Meningitidis DRC 0.000
1.231.432 Homocysteine DRC 0.625
1.231.432 Homocysteine IRC 1.080
1.235.1617 Deglutition DRC 0.324
1.235.1679 Foreign Body IRC 0.471
1.236.1155 Capsule Endoscopy DRC 0.325
1.236.312 Portal Hypertension DRC 0.000
1.243.1012 Vesicoureteral Reflux DRC 0.621
1.246.710 Rotavirus DRC 0.620
1.248.1317 Mycoplasma DRC 0.468
1.248.1317 Mycoplasma IRC 1.670
1.248.2104 Trichomonas Vaginalis IRC 0.983
1.248.655 Chlamydia Trachomatis DRC 0.772
1.248.655 Chlamydia Trachomatis IRC 1.343
1.257.983 Hydrocephalus IRC 1.570
1.258.1958 Leptospirosis IRC 0.373
1.258.227 Lyme Disease IRC 3.590
1.26.107 Adiponectin DRC 0.631
1.26.337 Leptin DRC 0.794
1.261.596 Trypanosoma Cruzi DRC 0.286
1.266.1068 Pressure Ulcer IRC 1.124
1.278.1796 Neuroblastoma DRC 0.057
1.281.1236 Amyloidosis IRC 0.816
1.286.845 Complement DRC 0.384
1.286.845 Complement IRC 0.193
1.324.2020 Tetanus DRC 0.766
1.34.1657 Elbow DRC 0.071
1.36.2059 Retinopathy Of Prematurity DRC 0.599
1.37.309 Congenital Heart Disease DRC 0.720
1.37.309 Congenital Heart Disease IRC 2.058
1.37.467 Echocardiography DRC 0.380
1.42.545 STEC DRC 0.000
1.42.545 STEC IRC 1.210
1.42.678 Listeria Monocytogenes DRC 0.331
1.42.678 Listeria Monocytogenes IRC 0.163
1.44.1198 Food Insecurity DRC 0.025
1.44.1198 Food Insecurity IRC 1.269
1.49.1061 Endodontics IRC 1.046
1.49.468 Oral Health DRC 1.001
1.49.468 Oral Health IRC 1.425
1.5.1674 Ketogenic Diet DRC 0.000
1.5.420 Cortisol IRC 1.267
1.54.1401 Genome Editing IRC 0.923
1.54.958 HMGB1 IRC 0.784
1.55.1904 ACE Gene DRC 0.229
1.55.830 Acute Kidney Injury DRC 0.213
1.6.351 Endotoxin DRC 0.890
1.6.351 Endotoxin IRC 0.936
1.6.452 Somatic Hypermutation DRC 0.000
1.6.609 Toll-like Receptors DRC 0.165
1.65.192 COPD IRC 187.114
1.66.11 HIV Prevalence & Prophylaxis DRC 0.346
1.66.11 HIV Prevalence & Prophylaxis IRC 1.884
1.66.1615 Aids Dementia Complex IRC 4.164
1.68.256 Docosahexaenoic Acid DRC 0.625
1.68.707 Alpha-Tocopherol IRC 1.361
1.71.2048 Mean Platelet Volume DRC 0.405
1.72.1072 Postpartum Depression DRC 2.411
1.72.1072 Postpartum Depression IRC 0.953
1.72.1710 Postpartum Hemorrhage DRC 0.000
1.72.1732 Patent Ductus Arteriosus DRC 0.586
1.72.1732 Patent Ductus Arteriosus IRC 0.571
1.72.1745 Hyperemesis Gravidarum DRC 0.295
1.72.1745 Hyperemesis Gravidarum IRC 0.731
1.72.182 Gestational Diabetes Mellitus DRC 0.799
1.72.182 Gestational Diabetes Mellitus IRC 0.927
1.72.531 Preeclampsia DRC 0.402
1.72.531 Preeclampsia IRC 1.026
1.72.748 Preterm Infants DRC 0.183
1.72.748 Preterm Infants IRC 0.918
1.72.808 Breech Presentation DRC 0.428
1.72.808 Breech Presentation IRC 1.143
1.72.891 Breastfeeding DRC 0.643
1.72.891 Breastfeeding IRC 1.024
1.72.922 Fetal Heart Rate DRC 0.555
1.72.922 Fetal Heart Rate IRC 0.883
1.72.924 Preterm Labor DRC 0.552
1.72.924 Preterm Labor IRC 1.029
1.75.326 Antiphospholipid Syndrome DRC 0.904
1.75.326 Antiphospholipid Syndrome IRC 0.297
1.80.279 Vitamin D DRC 0.669
1.80.279 Vitamin D IRC 0.611
1.81.1272 HLA-G DRC 0.554
1.81.1408 Fertility Preservation DRC 0.559
1.81.979 Twin-Twin Transfusion Syndrome DRC 0.260
1.81.979 Twin-Twin Transfusion Syndrome IRC 2.834
1.82.1066 Cerebral Palsy DRC 0.667
1.82.1066 Cerebral Palsy IRC 0.741
1.82.1298 Spinal Cord Injury Rehabilitation IRC 3.041
1.94.1664 VKORC1 DRC 0.081
1.95.387 Helicobacter Pylori DRC 0.466
1.95.723 Irritable Bowel Syndrome DRC 0.531
1.95.723 Irritable Bowel Syndrome IRC 0.721
1.95.801 Cimetidine IRC 0.233
3.16.1496 Ethnobotany DRC 0.658
3.171.1011 Carotenoids DRC 0.531
3.180.2418 Alginate Lyase DRC 0.425
3.198.400 Mycotoxins IRC 3.158
3.91.496 Cadmium DRC 0.000
3.91.920 Selenium DRC 0.119
3.91.920 Selenium IRC 0.425
4.61.1124 Rough Sets IRC 0.777
6.146.734 Anthropology IRC 2.034
6.178.516 Divorce IRC 2.074
6.24.858 Intimate Partner Violence DRC 7.091
6.24.858 Intimate Partner Violence IRC 3.483
6.73.2331 Health Locus of Control IRC 2.211
8.124.1648 Heat Waves IRC 0.666
8.124.552 Air Pollution DRC 0.126
8.124.552 Air Pollution IRC 0.631

Acronyms- Universities

University Acronyms University Acronyms
A.T. Still Univ ATSU-USA Ljubljana Univ Medical Centre Ljubliana UMC-SVN
Aalborg Univ AAU-DNK Lome Univ UL-TGO
Aarhus Univ AU-DNK London Univ UoL-GBR
Aberta Univ UAb-PRT Lorraine Univ UL-FRA
Abomey Calavi Univ UAC-BEN Los Andes Univ UANDES-CHL
Abuja Univ UNIABUJA-NGA Loughborough Univ Lboro-GBR
Addis Ababa Univ AAU-ETH Louisiana State Univ LSU-system-USA
Adelaid Univ AU-AUS Louisville Univ UofL-USA
Adigrat Univ AGU-ETH Loyola Univ Chicago LUC-USA
Aga Khan Univ AKU-KEN Lubumbashi Univ UNILU-ZAR
Aga Khan Univ AKU-PAK Ludwig Maximilians Univ Munich LMU Munich-DEU
Aga Khan Univ AKU-TZA Lund Univ LU-SWE
Ahfad Univ for Women AUW-SDN Lusaka Apex Medical Univ LAMU-ZMB
Ahmadu Bello Univ ABU-NGA Maastricht Univ UM-NLD
Ain Shams Univ ASU-EGY Macquarie Univ MQ-AUS
Al Azhar Univ Al-Zahar-EGY Madda Walabu Univ MWU-ETH
Al Neelain Univ Al Neelain-SDN Mahajanga Univ UMGA-MDG
Alabama Univ UA-System-USA Maharashtra Univ of Health Sciences MUHS-IND
Alazar Univ AI-Azar-EGY Mahidol Univ UM-THA
Albert Einstein College of Medicine Einstein-USA Maiduguri Univ UNIMAID-NGA
Alberta Univ UAlberta-CAN Makerere Univ Mak-UGA
Alborz Univ of Medical Sciences ABZUMS-IRN Malawi Univ UNIMA-MWI
Aleppo Univ ALEPUNIV-SYR Malawi Univ of Science and Technology MUST-MWI
Alexandria Univ AU-EGY Malaya Univ UM-MYS
Alfaisal Univ AU-SAU Management & Technology Univ UMT-PAK
Ambo Univ AU-ETH Manchester Univ UM-GBR
Amer Univ Beirut UAB-LBN Manitoba Univ UManitoba-CAN
Amrita Univ AU-IND Mansoura Univ MA-EGY
Amsterdam Univ UvA-NLD MARA Technological Univ UiTM-MYS
Anglia Ruskin Univ ARU-GBR Maragheh Univ of Medical Sciences MUMS-IRN
Ankara Yıldırım Beyazıt Univ AYBU-TUR Marmara Univ UM-TUR
Antwerp Univ UAntwerp-BEL Marshall Univ UM-USA
Applied Science Private Univ ASU-JOR Martin Luther Univ Halle-Wittenberg MLU-DEU
Arabian Gulf Univ AGU-BHR Maseno Univ MSU-KEN
Arak Univ of Medical Sciences AUMS-IRN Massachusetts Univ UMass-System-USA
Arba Minch Univ AMU-ETH Mazandaran Univ of Medical Sciences MazUMS-IRN
Arizona Univ UofA-USA Mbarara Univ of Science & Technology MUST-UGA
Arkansas State Univ ASU-System-USA McGill Univ McGill-CAN
Arkansas Univ UofA-System-USA McMaster Univ McMaster-CAN
Assiut Univ AUN-EGY Medical Sciences Univ UNIMED-NGA
Ateneo de Manila Univ Ateneo-PHL Medical Univ of Lodz MUL-POL
Auckland Univ UoA-NZL Medical Univ Vienna MedUni Vienna-AUT
Auckland Univ of Technology AUT-NZL Mekelle Univ MU-ETH
Australian Catholic Univ ACU-AUS Melbourne Univ UNIMELB-AUS
Australian National Univ ANU-AUS Menoufia Univ UM-EGY
Autonoma Chile univ Uautonoma-CHL Messina Univ UniME-ITA
Autonomous Univ of Madrid UAM-ESP Metropolitan Autonomous Univ UAM-MEX
Baba Farid Univ of Health Sciences BFUHS-IND Miami Univ UMiami-USA
Baghdad College of Medical Sciences BCMS-IRQ Michigan State Univ MSU-USA
Bahir Dar Univ BDU-ETH Michigan Univ UMich-System-USA
Balamand Univ UOB-LBN Milan Univ UNIMI-ITA
Ball State Univ BSU-USA Minia Univ Minia-EGY
Bamako Univ BU-MLI Minnesota Univ UofM-System-USA
Banaras Hindu Univ BHU-IND Misr Univ for Science and Technology MUST-EGY
Bangabandhu Sheikh Mujib Medical Univ BSMMU-BGD Missouri Univ UM-System-USA
Baqiyatallah Univ of Medical Sciences BMSU-IRN Mizan Tepi Univ MTU-ETH
Barcelona Univ UB-ESP Mohammed V Univ Mohammed V-MAR
Bari Univ UniBa-ITA Moi Univ MU-KEN
Basel Univ UB-CHE Monash Univ UM-AUS
Bath Univ UBath-GBR Monastir Univ UM-TUN
Bayero Univ BUK-NGA Montpellier Univ UMontpellier-FRA
Baylor College Medicine BCM-USA Montreal Univ UdeM-CAN
Baylor Univ UB-USA Morehouse School of Medicine MSM-USA
Belgrade Univ UB-SRB Moscow State Univ of Medicine and Dentistry MSUMD-RUS
Benghazi Univ UB-LBY Mountains of the Moon Univ MMU-UGA
Benha Univ BU-EGY Muhimbili Univ of Health and Allied Sciences MUHAS-TZA
Beni Suef Univ BSU-EGY Nacional de Colombia Univ UNAL-COL
Benin Univ UNIBEN-NGA Nagoya City Univ NCU-JPN
Bergen Univ UiB-NOR Nairobi Univ UoN-KEN
Bhaikaka Univ BU-IND Nanjing Univ NJU-CHN
Bielefeld Univ Uni Bielefeld-DEU Nanyang Technological Univ NTU-SGP
Birmingham Univ BU-GBR Nara Medical Univ NMU-JPN
BLDE Univ BLDE Univ-IND National Research Univ Higher School of Economics HSE Univ-RUS
Bologna Univ UNIBO-ITA National School of Public Health of Spain ENS-ESP
Bordeaux Segalen Univ BSU-FRA National Univ of Malaysia UKM-MYS
Bordeaux Univ UBordeaux-FRA National Univ of Singapore NUS-SGP
Boston Univ BU-USA Nazi Boni Univ UNB-BFA
Botswana Univ UB-BWA Nebraska Univ NU-System-USA
Bowen Univ BU-NGA New Mexico Univ UNM-USA
Brandeis Univ UBrandeis-USA New South Wales Univ UNSW-AUS
Brasilia Univ UnB-BRA New York Univ NYU-USA
Brigham Young Univ BYU-USA Newcastle Univ Newcastle Univ-GBR
Brighton and Sussex Medical School BSMS-GBR Nigeria Univ UNN-NGA
Bristol Univ UB-GBR Nnamdi Azikiwe Univ UNIZIK-NGA
British Columbia Univ UBC-CAN North Carolina Univ UNC-System-USA
Brown Univ UBrown-USA Northeastern Univ NEU-USA
Bucharest Univ of Economic Studies ASE-ROM Northumbria Univ NU-GBR
Burgundy Univ UB-FRA North-West Univ NWU-ZAF
Busitema Univ BU-UGA Northwestern Univ NU-USA
Cagliari Univ UNICA-ITA Obafemi Awolowo Univ OAU-NGA
Cairo Univ CU-EGY Occupational and Environmental Health Univ UOEH-JPN
Calabar Univ UNICAL-NGA Odisha Univ of Health Science OUHS-IND
Calgary Univ UCalgary-CAN Oklahoma State Univ System OSU-System-USA
California State Univ Cal State-USA Olabisi Onabanjo Univ OOU-NGA
California Univ UC-System-USA Oregon Health & Science Univ OHSU-USA
California Univ of Science and Medicine CUSM-USA Oslo Univ UiO-NOR
Cambridge Univ CAM-GBR Otago Univ UO-NZL
Can Tho Univ of Medicine and Pharmacy CTUMP-VNM Ottawa Univ uOttawa-CAN
Canberra Univ UC-AUS Ouagadougou Univ UO-BFA
Canterbury Univ UC-NZL Oulu Univ UniOulu -FIN
Cape Coast Univ UCC-GHA Oxford Univ OX-GBR
Cape Peninsula Univ of Technology CPUT-ZAF Oxford Univ Clinical Research Unit in Vietnam OUCRU-VNM
Cape Town Univ UCT-ZAF Padua Univ UniPD-ITA
Capital Medical Univ CCMU-CHN Papua New Guinea Univ UPNG -PNG
Carol Davila Univ of Medicine and Pharmacy UMFCD-ROM Paris 05 Univ Paris V-FRA
Cartagena Univ UNICARTAGENA-COL Paris 06 Univ UPMC-FRA
Carthage Univ UCAR-TUN Paris 11 Univ Paris XI-FRA
Case Western Reserve Univ CWRU-USA Parma Univ UNIPR-ITA
Catholic Univ of Graben UCG-ZAR Pavia Univ UNIPV-ITA
Catholic Univ of Health and Allied Sciences CUHAS-TZA Peking Univ PKU-CHN
Catholic Univ Portugal UCP-PRT Pennsylvania State Univ PSU-USA
Catolica de Pelotas Univ UCPEL-BRA Pennsylvania Univ UPenn-USA
Central Lancashire Univ UCLan-GBR Peoples Friendship Univ of Russia RUDN-RUS
Central South Univ CSU-CHN Peradeniya Univ UPeradeniya-LKA
CEU Cardenal Herrera Univ CEU-UCH-ESP Periyar Univ PU-IND
Charles Darwin Univ CDU-AUS Perugia Univ UNIPG-ITA
Charles R Drew Univ of Medicine & Science CDU-USA Philippines Manila Univ UPM-PHL
Charles Univ CU-CZE Philippines Univ UP-PHL
Chiang Mai Univ CMU-THA Philipps Univ of Marburg Marburg Univ-DEU
Chicago Univ UChicago-USA Pittsburgh Univ Pitt-USA
China Medical Univ CMU-CHN Pompeu Fabra Univ UPF-ESP
Chongqing Medical Univ CQMU-CHN Ponce Health Sciences Univ PHSU-USA
Chukwuemeka Odumegwu Ojukwu Univ ANSU-NGA Pontifícia Univ Catolica de Chile UC Chile-CHL
Chulalongkorn Univ CU-THA Pontificia Univ Javeriana PUJ-COL
Ciencias Aplicadas y Ambientales Univ UDCA-COL Port Harcourt Univ UNIPORT-NGA
City Univ of New York CUNY-USA Porto Univ UP-PRT
Clinical Centre of Serbia Univ UKCS-SRB Pretoria Univ UP-ZAF
Colgate Univ UColgate-USA Princeton Univ PU-USA
College Cork Univ UCC-IRL Purdue Univ Purdue-System-USA
College of Surgeons of East, Central and Southern Africa COSECSA-TZA Pwani Univ PU-KEN
Cologne Univ UoC-DEU Qassim Univ QU-SAU
Colombo Univ UoC-LKA Qazvin Univ of Medical Sciences QUMS-IRN
Colorado Univ CU-System-USA Qom Univ of Medical Science Qom MS-IRN
Columbia Univ CU-USA Queens Univ QU-CAN
Complutense de Madrid Univ UCM-ESP Queensland Univ UQ-AUS
Constantine the Philosopher Univ in Nitra UKF-SVK Queensland Univ Technology QUT-AUS
Contech School of Public Health CSPH-PAK Radboud Univ RU-NLD
Copenhagen Univ UCPH-DNK Rajiv Gandhi Univ RGU-IND
Cornell Univ UC-USA Rennes Univ Rennes-FRA
Costa Rica Univ UCR-CRI Republic Univ Udelar-URY
Curtin Univ WAIT-AUS Reykjavik Univ RU-ISL
Dalarna Univ DU-SWE Rhode Island Univ URI-USA
Dalhousie Univ Dal-CAN Rice Univ UR-USA
Danube Univ Krems UWK-AUT Rochester Univ URochester-USA
Dar es Salaam Univ UDSM-TZA Roma La Sapienza Univ Sapienza-ITA
Dartmouth College CDartmouth-USA Ross Univ School of Medicine RUSM-USA
Deakin Univ DU-AUS Rovira i Virgili Univ URV-ESP
Debre Berhan Univ DBU-ETH Rush Univ RU-USA
Debre Markos Univ DMU-ETH Rutgers Univ RU-System-USA
Delhi Univ DU-IND Rwanda Univ UR-RWA
Delta State Univ DELSU-NGA S Nijalingappa Medical College and HSK Hosp NMCBGK-IND
Dessie Health Science College DHSC-ETH Saint James School of Medicine SJSM-GBR
Development Studies Univ UDS-GHA Saint Joseph Univ SJU-USA
Dhaka Univ DU-BGD Saint Louis Univ SLU-USA
Diego Portales Univ UDP-CHL Saitama Medical Univ SMU-JPN
Dilla Univ DU-ETH Salahaddin Univ-Erbil SUE-IRQ
Dodoma Univ UDOM-TZA Salerno Univ UNISA-ITA
Douala Univ UDla-CMR Samara Univ SU-ETH
Drexel Univ UD-USA San Carlos de Guatemala Univ USAC-GTM
Duke Kunshan Univ DKU-CHN San Carlos Univ USC-PHL
Duke Univ DU-USA Sao Paulo Univ USP-BRA
Duke-NUS Medical School Duke-NUS-SGP Saskatchewan Univ uSask -CAN
Dundee Univ UD-GBR School of Medicine at Mount Sinai ISMMS-USA
Durban Univ of Technology DUT-ZAF Science Univ of Malaysia USM-MYS
Durham Univ DU-GBR Sciences de la Sante Univ USS-GAB
Dusseldorf Univ HHU-DEU Seoul National Univ SNU-KOR
Duy Tan Univ DTU-VNM Shahid Beheshti Univ of Medical Sciences SBUMS-IRN
East Anglia Univ UEA-GBR Shahjalal Univ of Science and Technology SUST-BGD
Eastern Finland Univ UEF-FIN Shandong Univ SDU-CHN
Eastern Virginia Medical School EVMS-USA Shanghai Jiao Tong Univ SJTU-CHN
Edinburgh Univ EU-GBR Sheffield Univ TUOS-GBR
Edith Cowan Univ ECU-AUS Shenzhen Univ SZU-CHN
Eduardo Mondlane Univ UEM-MOZ Sierra Leone Univ USL-SLE
Egas Moniz School of Health and Science ISCSEM-PRT Simmons Univ US-USA
Egerton Univ EU-KEN Simon Fraser Univ SFU-CAN
Emory Univ EU-USA Sousse Univ USO-TUN
Enugu State Univ of Science and Technology ESUT-NGA South Africa Univ UNISA-ZAF
Erasmus Univ Rotterdam EUR-NLD South Alabama Univ USA-USA
Estado Santa Catarina Univ UDESC-BRA South Australia Univ UniSA-AUS
Estadual Campinas Univ UNICAMP-BRA South Carolina Univ USC-System-USA
Ethiopian Defence Univ EDU-ETH Southampton Univ US-GBR
Exeter Univ UniofExter-GBR Southern Denmark Univ SDU-DNK
Extremadura Univ UEX-ESP Southern Univ College Southern UC-MYS
Federal da Bahia Univ UFBA-BRA Split Univ UNIST-HRV
Federal de Sao Paulo Univ UNIFESP-BRA Sri Ramachandra Univ SRU-IND
Federal do Ceara Univ UFC-BRA St Andrews Univ St Andrews-GBR
Federal Minas Gerais Univ UFMG-BRA St Augustine Univ of Tanzania SAUT-TZA
Federal Rio Grande do Sul Univ UFRGS-BRA St Luke International Univ LIU-JPN
Federal Santa Catarina Univ UFSC-BRA St Olaf College StOlaf-USA
Federal Sergipe Univ UFS-BRA St. Lawrence College SLC-CAN
Federal de Pelotas Univ UFPel-BRA St. Paul Hosp Millennium Medical College SPHMMC-ETH
Felix Houphouet-Boigny Univ UFHB-CIV Stanford Univ SU-USA
Ferhat Abbas Univ UFAS-DZA State Univ of Florida SUSF -USA
Flinders Univ FU-AUS State Univ of New York SUNY-USA
Florence Univ UNIFI-ITA State Univ of Semarang UNNES-IDN
FOM Univ FOM-DEU State Univ of Zanzibar SUZA-TZA
Fort Hare Univ UFH-ZAF Stavanger Univ UiS-NOR
Francisco Marroquin Univ UFM-GTM Stellenbosch Univ SU-ZAF
Freiburg Univ Uni Freiburg-DEU Stockholm Univ SU-SWE
Fribourg Univ UNIFR-CHE Strasbourg Univ UNISTRA-FRA
Friedrich Schiller de Jena Univ Jena Univ-DEU Suez Canal Univ SCU-EGY
Fudan Univ FDU-CHN Sul de Santa Catarina Univ UNISUL-BRA
Fujita Health Univ FHU-JPN Sun Yat Sen Univ SYSU-CHN
Gadarif Univ GU-SDN Sungkyunkwan Univ SKKU-KOR
Galway Univ NUIG-IRL Sydney Univ USYD-AUS
Geneve Univ UNIGE-CHE Sylhet Medical Univ SMU-BGD
George Mason Univ GMU-USA Taibah Univ TaibahU-SAU
George Washington Univ GWU-USA Taif Univ TU-SAU
Georgetown Univ GU-USA Taishan Medical Univ TSU-CHN
Georgia Univ UG-System-USA Tamil Nadu Dr. M.G.R. Medical Univ TNMGRMU-IND
Gezira Univ UofG-SDN Tampere Univ TAU-FIN
Ghana Univ UG-GHA Tanta Univ TU-EGY
Ghent Univ UGent-BEL Tartu Univ UT-EST
Golestan Univ of Medical Sciences GOUMS-IRN Tasmania Univ UTAS-AUS
Gondar Univ UoG-ETH Tbilisi State Medical Univ TSMU-GEO
Gothenburg Univ GU-SWE Technology Sydney Univ UTS-AUS
Griffith Univ GU-AUS Tehran Univ of Medical Sciences TUMS-IRN
Groningen Univ RUG-NLD Tennessee Univ UTennessee-System-USA
Guelph Univ UofG-CAN Texas Tech Univ TTU-System-USA
Hacettepe Univ HU-TUR Texas Univ UT-System-USA
Hail Univ UOH-SAU The College of New Jersey TCNJ-USA
Hamadan Univ of Medical Sciences and Health Services UMSHA-IRN Thessaly Univ UTH-GRC
Hamdan Bin Mohammed Smart Univ HBMSU-ARE Thomas Jefferson Univ TJU-USA
Hanoi Medical Univ HMU-VNM Tokyo Univ Utokyo-JPN
Haramaya Univ HU-ETH Tor Vergata Univ of Rome Tor Vergata-ITA
Harvard Univ HU-USA Toronto Univ UToronto-CAN
Hasselt Univ Uhasselt-BEL Touro Univ System Touro-System-USA
Hawaii Univ UH-System-USA Tribhuvan Univ TU-NPL
Health Sciences Univ UHS Lahore Trieste Univ UniTS-ITA
Health Sciences Univ UHS Lahore-PAK Tripoli Univ UOT-LBY
Hebrew Univ of Jerusalem HUJI-ISR Trnava Univ TU-SVK
Heidelberg Univ Uni Heidelberg-DEU Tromso Univ UiT-NOR
Helsinki Univ UH-FIN Tubingen Univ Uni Tubingen-DEU
Helwan Univ HU-EGY Tufts Univ UT-USA
Higher National Veterinary School ENSV-DZA Tulane Univ TU-USA
Hohenheim Univ Uni Hohenheim-DEU Tumaini Univ Makumira TUMa-TZA
Hong Kong Polytechnic Univ PolyU-CHN Tunis El Manar Univ UTM-TUN
Hong Kong Univ HKU-CHN Turin Univ UniTo-ITA
Howard Univ UHoward-USA Tyrolean Private Univ UMIT TIROL-AUT
Huazhong Univ of Science and Technology HUST-CHN Uganda Christian Univ UCU-UGA
Hue Univ HU-VNM Ulm Univ Ulm-DEU
Ibadan Univ UI-NGA Umea Univ UMU-SWE
Idaho Univ UIdaho-USA Umm Al-Qura Univ UQU-SAU
Illinois Univ UI-System-USA Union Univ UU-USA
Ilorin Univ UNILORIN-NGA United Arab Emirates Univ UAEU-ARE
Imperial College London UImperial-GBR Univ Internacional de Catalunya UIC-ESP
Indiana Univ IU-System-USA Univ Medical Group UMG-USA
Indonesia Univ UI-IDN Univ of Health and Allied Sciences UHAS-GHA
International Medical Univ IMU-MYS Univ of Medicine and Dentistry of New Jersey UMDNJ-USA
Iowa Univ UIowa-USA Univ of Medicine Tirana UMT-ALB
Iran Univ of Medical Sciences IUMS-AUS Univ of Pittsburgh Medical Center UPMC-USA
Iran Univ of Medical Sciences IUMS-IRN Univ of the East Ramon Magsaysay Memorial Medical Center UERMMMC-PHL
ISHIK Univ ISHIK Univ-IRQ Univ Research Co LLC URC-USA
Jackson State Univ JSU-USA Univ System of Georgia USG-USA
Jagiellonian Univ JU-POL Univ System of Maryland NIAID-USA
James Cook Univ JCU-AUS Univ System of Maryland USM-System-USA
Jazan Univ JazanU-SAU Univ System of Ohio UO-System-USA
Jean Lorougnon Guede Univ UJLG-CIV Uppsala Univ UU-SWE
Jichi Medical Univ JMU-JPN Usmanu Danfodiyo Univ UDUS-NGA
Jilin Univ JLU-CHN Utkal Univ UU-IND
Jimma Univ JU-ETH Utrecht Univ UU-NLD
Jinan Univ JNU-CHN Valencia Univ UV-ESP
Johns Hopkins Univ JHU-USA Vanderbilt Univ Vandy-USA
Jomo Kenyatta Univ of Agriculture and Technology JKUAT-KEN Venda Univ UNIVEN-ZAF
Jordan Univ of Science and Technology JUST-JOR Versailles – Saint-Quentin-en-Yvelines Univ UVSQ-FRA
Jos Univ UNIJOS-NGA Victoria Univ VU-CAN
Jouf Univ JU-SAU Vilnius Univ VU-LTU
Julius Maximilian Univ of Wurzburg JMU-DEU Virginia Commonwealth Univ VCU-USA
Justus Liebig Univ Giessen JLU-DEU Virginia Polytechnic Institute and State Univ Virginia Tech-USA
Kansas Univ KU-USA Virginia Univ UVA-USA
Karabuk Univ KBU-TUR Vrije Univ Amsterdam VU Amsterdam-NLD
Karolinska Institute KI-SWE Wageningen Univ & Research WUR-NLD
Kassala Univ KU-SDN Wake Forest Univ WFU-USA
Kathmandu Univ KU-NPL Walden Univ WaldenU-USA
Katholieke Univ Leuven KU Leuven-BEL Warwick Univ UW-GBR
Kazakh National Medical Univ KazNMU-KAZ Washington Kenya Univ UW-KEN
Kentucky Univ UKY-USA Washington State Univ WSU-System -USA
Kenyatta Univ KU-KEN Washington Univ UW-USA
Kerman Univ of Medical Sciences KMU-IRN Washington Univ in St Louis WUSTL-USA
Kermanshah Univ of Medical Sciences KUMS-IRN Wayne State Univ WSU-USA
Khartoum Univ UofK-SDN Weill Cornell Medical College WCM-Q-QAT
Khon Kaen Univ KKU-THA Wenzhou Medical Univ WMU-CHN
King Abdulaziz Univ KAU-SAU West Indies Univ UWI-JAM
King George Medical Univ KGMU-IND West of England Univ UWE-GBR
King Saud bin Abdulaziz Univ for Health Sciences KSAU-HS-SAU West Virginia Univ WVU System-USA
King Saud Univ KSU-SAU Western Australia Univ UWA-AUS
Kinshasa Univ UNIKIN-ZAR Western Cape Univ UWC-ZAF
KLE Univ KLE Univ-IND Western Kentucky Univ WKU-USA
Koc Univ KU-TUR Western Ontario Univ UWO-CAN
Korea Univ KU-KOR Western Sydney Univ UWS-AUS
Kosin Univ UK-KOR Wisconsin Univ UW System-USA
Kragujevac Univ UK-SRB Witwatersrand Univ Wits Univ-ZAF
Kurdistan Univ of Medical Sciences MUK-IRN Wolaita Sodo Univ WSU-ETH
Kwame Nkrumah Univ of Science and Technology KNUST-GHA Wollega Univ WU-ETH
KwaZulu-Natal Univ UKZN-ZAF Wollongong Univ UOW-AUS
Kyoto Univ Kyoto U-JPN Women College Research Institute WCRI-CAN
Kyung Hee Univ KHU-KOR Wrocław Medical Univ WMU-POL
La Trobe Univ LaTrobeU-AUS Xi an Jiaotong Univ XJTU-CHN
Ladoke Akintola Univ of Technology LAUTECH-NGA Xiamen Univ XMU-MYS
Lagos State Univ LASU-NGA Yale Univ YU-USA
Lagos Univ UNILAG-NGA Yaounde I Univ UYI-CMR
Lahore College for Women Univ LCWU-PAK Yokohama City Univ YCU-JPN
Lancaster Univ ULancaster-GBR Yonsei Univ YU-KOR
Latvia Univ UL-LVA York Univ York Univ-CAN
Lausanne Univ UNIL-CHE York Univ York Univ-GBR
Leeds Univ ULeeds-GBR Zagazig Univ ZU-EGY
Leicester Univ UL-GBR Zahedan Univ Medical Sciences ZUMS-IRN
Leiden Univ LEI-NLD Zambia Univ UNZA-ZMB
Libre Bruxelles Univ ULB-BEL Zayed Univ ZU-ARE
Libyan International Medical Univ LIMU-LBY Zhejiang Univ ZJU-CHN
Limoges Univ UNILIM-FRA Ziekenhuis Brussel Univ UZ Brussel-BEL
Lincoln Univ LU-GBR Zimbabwe Univ UZ-ZWE
Lisbon Univ ULisboa-PRT Zurich Univ UZH-CHE
Lithuanian Univ of Health Sciences LSMU-LTU

References

  1. Atal, I.; Trinquart, L.; Ravaud, P.; Porcher, R. A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non high-income regions. Journal of Clinical Epidemiology 2018, 98, 123–132. [Google Scholar] [CrossRef] [PubMed]
  2. Cerdeira, J.; Mesquita, J.; Vieira, E.S. International research collaboration: Is Africa different? A cross-country panel data analysis. Scientometrics 2023, 128(4), 2145–2174. [Google Scholar] [CrossRef]
  3. Cherven, K. Mastering Gephi network visualization: Produce advanced network graphs in Gephi and gain valuable insights into your network datasets; Packt Publishing: Birmingham, UK, 2015. [Google Scholar]
  4. Clarivate. InCites Indicators Handbook. 2021. Available online: https://incites.help.clarivate.com/Content/Indicators-Handbook/ih-about.htm.
  5. Confraria, H.; Wang, L. Medical research versus disease burden in Africa. Research Policy 2020, 49(3). [Google Scholar] [CrossRef]
  6. Evans, J.A.; Shim, J.M.; Ioannidis, J.P.A. Attention to Local Health Burden and the Global Disparity of Health Research. PLoS ONE 2014, 9(4). [Google Scholar] [CrossRef] [PubMed]
  7. Liu, L.; Johnson, H.L.; Cousens, S.; Perin, J.; Scott, S.; Lawn, J.E.; Rudan, I.; Campbell, H.; Cibulskis, R.; Li, M.; et al. Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379(9832), 2151–2161. [Google Scholar] [CrossRef] [PubMed]
  8. Mouton, J.; Blanckenberg, J. African science: A bibliometric analysis. In The Next Generation of Scientists in Africa; Beaudry, C., Mouton, J., Prozesky, H., Eds.; African Minds: Cape Town, South Africa, 2018. [Google Scholar]
  9. Newman, M.E.J. Clustering and preferential attachment in growing networks. Physical Review E 2001, 64(2). [Google Scholar] [CrossRef] [PubMed]
  10. Nieuwoudt, L.; Mackay, C.A.; Mda, S. Causes of and Modifiable Factors Contributing to Neonatal Deaths at Dora Nginza Hospital in the Eastern Cape, South Africa. Global Pediatric Health 2022, 9. [Google Scholar] [CrossRef] [PubMed]
  11. Ou, Z.; Yu, D.; Liang, Y.; He, H.; He, W.; Li, Y.; Zhang, M.; Gao, Y.; Wu, F.; Chen, Q. Global trends in incidence and death of neonatal disorders and its specific causes in 204 countries/territories during 1990–2019. Bmc Public Health 2022, 22(1). [Google Scholar] [CrossRef] [PubMed]
  12. Owusu-Nimo, F.; Boshoff, N. Research collaboration in Ghana: Patterns, motives and roles. Scientometrics 2017, 110(3), 1099–1121. [Google Scholar] [CrossRef]
  13. Potter, I. Introducing Citation Topics in InCites. 2020. Available online: https://clarivate.com/blog/introducing-citation-topics/.
  14. Sooryamoorthy, R. Science in Africa: Contemporary Trends in Research. Journal of Scientometric Research 2021, 10(3), 366–372. [Google Scholar] [CrossRef]
  15. Stefanoudis, P.V.; Licuanan, W.Y.; Morrison, T.H.; Talma, S.; Veitayaki, J.; Woodall, L.C. Turning the tide of parachute science. Current Biology 2021, 31(4), R184–R185. [Google Scholar] [CrossRef] [PubMed]
  16. UN. The Sustainable Development Goals Report. 2022. Available online: https://unstats.un.org/sdgs/report/2022/The-Sustainable-Development-Goals-Report-2022.pdf.
  17. UN. Newborn mortality. 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/newborn-mortality.
  18. Vieira, E.S. The influence of research collaboration on citation impact: The countries in the European Innovation Scoreboard. Scientometrics 2023, 128(6), 3555–3579. [Google Scholar] [CrossRef]
  19. Vieira, E.S.; Cerdeira, J. The integration of African countries in international research networks. Scientometrics 2022, 127(4), 1995–2021. [Google Scholar] [CrossRef]
  20. Vieira, E.S.; Gomes, J. Citations to scientific articles: Its distribution and dependence on the article features. Journal of Informetrics 2010, 4(1), 1–13. [Google Scholar] [CrossRef]
  21. Waltman, L. A review of the literature on citation impact indicators. Journal of Informetrics 2016, 10(2), 365–391. [Google Scholar] [CrossRef]
  22. Wang, H.; A Liddell, C.; Coates, M.M.; Mooney, M.D.; E Levitz, C.; E Schumacher, A.; Apfel, H.; Iannarone, M.; Phillips, B.; Lofgren, K.T.; et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384(9947), 957–979. [Google Scholar] [CrossRef] [PubMed]
  23. WHO. A heavy burden: The productivity cost of illness in Africa. 2019.
Figure 1. The total number of articles on NC research in Africa. For the graph on the left, the trendline is as follows y = 7.1842 e x p 0.1762 x (r-square=0.9831).
Figure 1. The total number of articles on NC research in Africa. For the graph on the left, the trendline is as follows y = 7.1842 e x p 0.1762 x (r-square=0.9831).
Preprints 119956 g001
Figure 2. Evolution of the CNCI of NC research. The number of articles is below 20 between 2000 and 2007 (each year). For these years, the results are shown for information purposes and not for discussion.
Figure 2. Evolution of the CNCI of NC research. The number of articles is below 20 between 2000 and 2007 (each year). For these years, the results are shown for information purposes and not for discussion.
Preprints 119956 g002
Figure 3. Distribution of articles by topic. Only the top 5 topics, according to the number of articles, are shown.
Figure 3. Distribution of articles by topic. Only the top 5 topics, according to the number of articles, are shown.
Preprints 119956 g003
Figure 4. Evolution of DRC, IRC and articles without collaboration (no_coll). For IRC and DRC curves, the trendlines are as follows: IRC- y = 2.7304 e x p 0.2055 x (r-square = 0.9622); DRC- y = 4.0071 e x p 0.1563 x (r-square = 0.9448).
Figure 4. Evolution of DRC, IRC and articles without collaboration (no_coll). For IRC and DRC curves, the trendlines are as follows: IRC- y = 2.7304 e x p 0.2055 x (r-square = 0.9622); DRC- y = 4.0071 e x p 0.1563 x (r-square = 0.9448).
Preprints 119956 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated